US20090287303A1 - Physiologically harmonized tricuspid annuloplasty ring - Google Patents
Physiologically harmonized tricuspid annuloplasty ring Download PDFInfo
- Publication number
- US20090287303A1 US20090287303A1 US12/120,184 US12018408A US2009287303A1 US 20090287303 A1 US20090287303 A1 US 20090287303A1 US 12018408 A US12018408 A US 12018408A US 2009287303 A1 US2009287303 A1 US 2009287303A1
- Authority
- US
- United States
- Prior art keywords
- segment
- ring
- free end
- ring body
- septal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2445—Annuloplasty rings in direct contact with the valve annulus
- A61F2/2448—D-shaped rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2445—Annuloplasty rings in direct contact with the valve annulus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0018—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in elasticity, stiffness or compressibility
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0019—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in hardness, e.g. Vickers, Shore, Brinell
Definitions
- the present invention relates generally to medical devices and particularly to a tricuspid annuloplasty ring.
- the heart is a hollow muscular organ having four pumping chambers: the left and right atria and the left and right ventricles, each provided with its own one-way valve.
- the natural heart valves are identified as the aortic, mitral (or bicuspid), tricuspid and pulmonary, and are each mounted in an annulus comprising dense fibrous rings attached either directly or indirectly to the atrial and ventricular muscle fibers. Each annulus defines a flow orifice.
- Heart valve disease is a widespread condition in which one or more of the valves of the heart fails to function properly.
- Diseased heart valves may be categorized as either stenotic, wherein the valve does not open sufficiently to allow adequate forward flow of blood through the valve, and/or incompetent, wherein the valve does not close completely, causing excessive backward flow of blood through the valve when the valve is closed.
- Valve disease can be severely debilitating and even fatal if left untreated.
- Various surgical techniques may be used to repair a diseased or damaged valve.
- the damaged leaflets are excised and the annulus sculpted to receive a replacement valve.
- Another less drastic method for treating defective valves is through repair or reconstruction, which is typically used on minimally calcified valves.
- the most widely used repair technique is remodeling annuloplasty first proposed by the same inventor in which the deformed valve annulus is reshaped by attaching a prosthetic annuloplasty repair segment or ring to the valve annulus.
- the annuloplasty ring is designed to support the functional changes that occur during the cardiac cycle: maintaining coaptation and valve integrity to prevent reverse flow while permitting good hemodynamics during forward flow.
- the present invention relates generally to medical devices and particularly to a tricuspid annuloplasty ring.
- the heart is a hollow muscular organ having four pumping chambers: the left and right atria and the left and right ventricles, each provided with its own one-way valve.
- the natural heart valves are identified as the aortic, mitral (or bicuspid), tricuspid and pulmonary, and are each mounted in an annulus comprising dense fibrous rings attached either directly or indirectly to the atrial and ventricular muscle fibers. Each annulus defines a flow orifice.
- Heart valve disease is a widespread condition in which one or more of the valves of the heart fails to function properly.
- Diseased heart valves may be categorized as either stenotic, wherein the valve does not open sufficiently to allow adequate forward flow of blood through the valve, and/or incompetent, wherein the valve does not close completely, causing excessive backward flow of blood through the valve when the valve is closed.
- Valve disease can be severely debilitating and even fatal if left untreated.
- Various surgical techniques may be used to repair a diseased or damaged valve.
- the damaged leaflets are excised and the annulus sculpted to receive a replacement valve.
- Another less drastic method for treating defective valves is through repair or reconstruction, which is typically used on minimally calcified valves.
- the most widely used repair technique is remodeling annuloplasty first proposed by the same inventor in which the deformed valve annulus is reshaped by attaching a prosthetic annuloplasty repair segment or ring to the valve annulus.
- the annuloplasty ring is designed to support the functional changes that occur during the cardiac cycle: maintaining coaptation and valve integrity to prevent reverse flow while permitting good hemodynamics during forward flow.
- the annuloplasty ring typically comprises an inner substrate of a metal such as rods or bands of stainless steel or titanium, or a flexible material such as silicone rubber or Dacron cordage, covered with a biocompatible fabric or cloth to allow the ring to be sutured to the fibrous annulus tissue.
- Annuloplasty rings may be stiff or flexible, split or continuous, and may have a variety of shapes, including circular, U-shaped, C-shaped, or kidney-shaped. Examples are seen in U.S. Pat. Nos. 5,041,130, 5,104,407, 5,201,880, 5,258,021, 5,607,471 and, 6,187,040 B1.
- annuloplasty rings Whether totally flexible, rigid, or semi-rigid, annuloplasty rings have sometimes been associated with a certain degree of arrhythmia or a 10% to 15% incidence at 10 years of ring dehiscence and/or conduction tissue disturbance.
- the present invention is intended to reduce the complications.
- FIG. 1 is a schematic representation of the AV junctions within the heart and the body in the left anterior oblique projection.
- the body is viewed in the upright position and has 3 orthogonal axes: superior-inferior, posterior-anterior, and right-left.
- Traditional nomenclature for the AV junctions derives from a surgically distorted view, placing the valvular rings in a single horizontal plane with antero-posterior and right-left lateral coordinates.
- the descriptive terms used, however, are anatomically inaccurate.
- An accurate account of the coordinates of the valvular orifices is provided by the simple expedient of relating appropriately the view obtained in left anterior oblique projection to the supero-inferior and antero-posterior coordinates of the body.
- FIG. 2 is a cutaway view of the heart from the front, or anterior, perspective, with most of the primary structures marked.
- the pathway of blood in the heart is from the right atrium to the right ventricle through the tricuspid valve, to and from the lungs, and from the left atrium to the left ventricle through the mitral valve.
- the present application has particular relevance to the repair of the tricuspid valve, which regulates blood flow between the right atrium and right ventricle, although certain aspects may apply to repair of other of the heart valves.
- the tricuspid and mitral valves together define the atrioventricular (AV) junctions.
- AV atrioventricular
- SA node sinoatrial node
- AV node atrioventricular node
- Purkinje fibers On the rear wall of the right atrium is a barely visible knot of tissue known as the sinoatrial, or SA node. This tiny area is the control of the heart's pacemaker mechanism.
- Impulse conduction normally starts in the SA node. It generates a brief electrical impulse of low intensity approximately 72 times every minute in a resting adult.
- the impulses reach the AV node they are relayed by way of the several bundles of His and Purkinje fibers to the ventricles, causing them to contract.
- the integrity and proper functioning of the conductive system of the heart is critical for good health.
- FIG. 3 is a schematic view of the tricuspid valve orifice seen from its inflow side (from the right atrium), with the peripheral landmarks labeled as: antero septal commissure, anterior leaflet, posterior commissure, posterior leaflet, postero septal commissure, and septal leaflet. Contrary to traditional orientation nomenclature, the tricuspid valve is nearly vertical, as reflected by these sector markings. From the same viewpoint, the tricuspid valve 20 is shown surgically exposed in FIG. 4 with an annulus 22 and three leaflets 24 a , 24 b , 24 c extending inward into the flow orifice. Chordae tendineae 26 connect the leaflets to papillary muscles located in the RV to control the movement of the leaflets.
- the tricuspid annulus 22 is an ovoid-shaped fibrous ring at the base of the valve that is less prominent than the mitral annulus, but larger in circumference.
- the three leaflets in FIG. 4 are identified as septal 24 a , anterior 24 b , and posterior (or “mural”) 24 c .
- the leaflets join together over three prominent zones of apposition, and the peripheral intersections of these zones are usually described as commissures 28 .
- the leaflets 24 are tethered at the commissures 28 by the fan-shaped chordae tendineae 26 arising from prominent papillary muscles originating in the right ventricle.
- the septal leaflet 24 a is the site of attachment to the fibrous trigone, the fibrous “skeletal” structure within the heart.
- the anterior leaflet 24 b largest of the 3 leaflets, often has notches.
- the posterior leaflet 24 c smallest of the 3 leaflets, usually is scalloped.
- the ostium 30 of the right coronary sinus opens into the right atrium, and the tendon of Todaro 32 extends adjacent thereto.
- the AV node 34 and the beginning of the bundle of His 36 are located in the supero-septal region of the tricuspid valve circumference.
- the AV node 34 is situated directly on the right atrial side of the central fibrous body in the muscular portion of the AV septum, just superior and anterior to the ostium 30 of the coronary sinus 30 . Measuring approximately 1.0 mm ⁇ 3.0 mm ⁇ 6.0 mm, the node is flat and oval.
- the AV node 34 is located at the apex of the triangle of Koch 38 , which is formed by the tricuspid annulus 22 , the ostium 30 of the coronary sinus, and the tendon of Todaro 32 .
- the AV node 34 continues on to the bundle of His 36 , typically via a course inferior to the commissure 28 between the septal 24 a and anterior 24 b leaflets of the tricuspid valve; however, the precise course of the bundle of His 36 in the vicinity of the tricuspid valve may vary. Moreover, the location of the bundle of His 36 may not be readily apparent from a resected view of the right atrium because it lies beneath the annulus tissue.
- the triangle of Koch 30 and tendon of Todaro 32 provide anatomic landmarks during tricuspid valve repair procedures.
- a major factor to consider during surgery is the proximity of the conduction system (AV node 34 and bundle of His 36 ) to the septal leaflet 24 a .
- AV node 34 and bundle of His 36 the conduction system
- surgeons must avoid placing sutures too close to or within the AV node 34 .
- C-shaped rings are good choices for tricuspid valve repairs because they allow surgeons to position the break in the ring adjacent the AV node 34 , thus avoiding the need for suturing at that location.
- a rigid C-shaped ring of the prior art is the Carpentier-Edwards Classic® Tricuspid Annuloplasty Ring sold by Edwards Lifesciences Corporation of Irvine, Calif., which is seen in FIGS. 5A and 5B .
- the planar ring 40 has an inner titanium core (not shown) covered by a layer of silicone and fabric. Rings for sizes 26 mm through 36 mm in 2 mm increments have outside diameters (OD) between 31.2-41.2 mm, and inside diameters (ID) between 24.3-34.3 mm. These diameters are taken along the “diametric” line spanning the greatest length across the ring because that is the conventional sizing parameter.
- a gap G between free ends 42 a , 42 b in each provides the discontinuity to avoid attachment over the AV node 34 .
- the gap G for the various sizes ranges between about 5-8 mm, or between about 19%-22% of the labeled size.
- the gap G is sized just larger than the AV node 34 . Despite this clearance, some surgeons are uncomfortable passing sutures so close to the conductive AV node 34 , particularly considering the additional concern of the bundle of His 36 .
- a flexible C-shaped tricuspid ring is sold under the name SoveringTM by Sorin Biomedica Cardio S.p.A. of Via Crescentino, Italy.
- the SoveringTM is made with a radiopaque silicone core covered with a knitted polyester (PET) fabric so as to be totally flexible. Rings for sizes 28 mm through 36 mm in 2 mm increments have outside diameters (OD) between 33.8-41.8 mm, and inside diameters (ID) between 27.8-35.8 mm.
- OD outside diameters
- ID inside diameters
- a gap between the free ends provides a discontinuity to avoid attachment over the AV node.
- the gap for the various sizes ranges between about 18-24 mm, or between about 60%-70% of the labeled size. Although this gap helps avoid passing sutures close to the conductive AV node 34 and bundle of His 36 , the ring is designed to be attached at the commissures on either side of the septal leaflet and thus no support is provided on the septal side.
- the present invention provides a tricuspid annuloplasty ring including a ring body generally arranged in a plane and about an axis along an inflow-outflow direction, the ring body being discontinuous so as to define a first free end and a second free end separated across a gap, the two free ends being bent out of the plane in an inflow direction.
- the two free ends are flexible and can be bent to have an axial height of between about 1-4 mm out of the plane.
- the ring body defines a generally asymmetric ovoid shape and extends in a clockwise direction from a first free end located adjacent the antero-septal commissure when implanted, as seen looking at the inflow side thereof, around a first segment, a second segment, a third segment, and a fourth segment that terminates in the second free end at a septal point.
- the ring body has an arcuate bulge out of the plane toward the inflow side at the first segment to accommodate an anatomical bulge of the aorta into the tricuspid annulus.
- the ring body has an arcuate bulge out of the plane toward the inflow side at the fourth segment to accommodate an anatomical bulge of the aorta into the tricuspid annulus. Still further, the ring body desirably has a varying flexibility and is stiffer adjacent the first free end than adjacent the second free end, or comprises at least one hinge point that is locally more flexible than adjacent segments. In one preferred construction, the ring body comprises a plurality of concentric peripheral bands having an axial dimension which is larger adjacent the first free end than adjacent the second free end. In a preferred embodiment, the ring has a long dimension in millimeters, and the free ends are separated by a distance of between about 40%-50% of the long dimension.
- a prosthetic tricuspid annuloplasty ring having a long dimension in millimeters, comprises an asymmetric generally ovoid ring body.
- the ring body is generally arranged in a plane and about an axis along an inflow-outflow direction and is discontinuous so as to define two free ends.
- the ring body has a length and shape such that if a first free end is implanted adjacent an antero septal commissure of the tricuspid annulus, the ring body conforms to the tricuspid annulus and a second end is located adjacent a septal leaflet thereof, and the free ends are separated across a gap having a dimension of between about 40%-50% of the long dimension.
- the ring body extends in a clockwise direction from the first free end, as seen looking at the inflow side thereof around a first segment, a second segment, a third segment, and a fourth segment that terminates in the second free end at a septal point.
- the ring body has an arcuate bulge out of the plane toward the inflow side at the first segment to accommodate an anatomical bulge of the aorta into the tricuspid annulus.
- the ring body has an arcuate bulge out of the plane toward the inflow side at the fourth segment.
- the ring body desirably has a varying flexibility and is stiffer adjacent the first free end than adjacent the second free end, or comprises at least one hinge point that is locally more flexible than adjacent segments.
- a prosthetic tricuspid annuloplasty ring comprises an asymmetric generally ovoid ring body generally arranged in a plane and about an axis along an inflow-outflow direction with a first free end located adjacent an antero-septal commissure when implanted and a second free end located at a septal point.
- the ring body extends in a clockwise direction as seen looking at an inflow side from the first free end around a first segment, a second segment, a third segment, and a fourth segment that terminates in the second free end.
- the ring body has an arcuate bulge out of the plane toward the inflow side at the first segment so as to accommodate an anatomical bulge of the aorta into the tricuspid annulus.
- the ring body may also have an arcuate bulge out of the plane toward the inflow side at the fourth segment.
- the ring body has a varying flexibility and the fourth segment is relatively more flexible than the third segment.
- the first free end may also be stiffer than the second free end.
- the varying flexibility comprises at least one hinge point that is locally more flexible than adjacent segments.
- asymmetric generally ovoid ring body generally arranged in a plane and about an axis along an inflow-outflow direction with a first free end located adjacent an antero-septal commissure when implanted and a second free end located at a septal point.
- the ring body extends in a clockwise direction as seen looking at an inflow side from the first free end around a first segment, an second segment, a third segment, and a fourth segment that terminates in the second free end.
- the ring body has a variable flexibility comprising at least one hinge point that is locally more flexible than adjacent segments. Desirably, the hinge point is located at the approximate midpoint of the ring body. Alternatively, there are two hinge points located approximately diametrically opposite one another so that the ring flexes generally in a plane.
- FIG. 1 is a schematic representation of the AV junctions within the heart and the body in the left anterior oblique projection
- FIG. 2 is a cutaway view of the heart from the front, or anterior, perspective
- FIG. 3 is a schematic plan view of the tricuspid annulus with typical orientation directions noted as seen from the inflow side;
- FIG. 4 is a plan view of the native tricuspid valve and surrounding anatomy from the inflow side;
- FIG. 6 is a plan view of the native tricuspid valve and surrounding anatomy from the inflow side with the annuloplasty ring of FIGS. 5A-5B implanted;
- FIGS. 7A-7C are plan and septal and anterior elevational views, respectively, of an exemplary tricuspid annuloplasty ring of the present invention illustrating its free ends bent toward the inflow side and an antero-superior bulge;
- FIG. 8 is a plan view of the native tricuspid valve and surrounding anatomy from the inflow side with the annuloplasty ring of FIGS. 7A-7B implanted;
- FIGS. 9A-9C are plan and septal and anterior elevational views, respectively, of the exemplary tricuspid annuloplasty ring of FIGS. 7A-7B with portions cutaway to show internal details;
- FIGS. 10A-10D are sectional views taken along respective section lines in FIG. 9A .
- the present invention provides an improved tricuspid annuloplasty ring that better conforms to the native annulus and is shaped to protect certain features of the surrounding anatomy.
- the ring of the present invention is designed to support a majority of the tricuspid annulus without risking injury to the leaflet tissue and heart's conductive system, such as the AV node 34 and bundle of His 36 (see FIG. 4 ).
- the present ring is contoured to better approximate the three-dimensional shape of the tricuspid annulus; specifically, the ring is substantially planar but includes a bulge in the inflow direction at the location of the bulge created by the adjacent aorta. The bulge helps reduce stress between the ring and surrounding tissue, and thus the potential for tearing or ring dehiscence.
- Another feature that matches the present tricuspid ring with the physiological features of the annulus is a variable flexibility from a relatively stiff first segment to a relatively flexible fourth segment.
- This varying flexibility permits the ring to adapt (harmonize) its motion and 3-dimensional shape to that of the annulus, rather than impose its own motion and 3-D geometry thereto which tends to increase the risk of ring dehiscence.
- the motion of the tricuspid annulus during systole-diastole is believed to exert some torsional forces on the implanted ring, and the variable flexibility accommodates such torques.
- localized points of flexibility or “hinges” around the ring as described herein may best conform and harmonize the physical properties of the ring to the annulus motion, while at the same time providing the needed corrective support.
- the present tricuspid ring might also be applicable and beneficial to rings for other of the heart's annuluses.
- the present ring includes upturned or bent free ends that help reduce abrasion on the adjacent leaflets.
- the same structure might be used in a discontinuous ring for the mitral valve annulus.
- axis in reference to the illustrated ring, and other non-circular or non-planar rings, refers to a line generally perpendicular to the ring that passes through the area centroid of the ring when viewed in plan view. “Axial” or the direction of the “axis” can also be viewed as being parallel to the direction of blood flow within the valve orifice and thus within the ring when implanted therein. Stated another way, the implanted tricuspid ring orients about a central flow axis aligned along an average direction of blood flow through the tricuspid annulus.
- the rings of the present invention are 3-dimensional, portions thereof are planar and lie perpendicular to the flow axis.
- FIGS. 7A-7C illustrate, in plan and septal and anterior elevational views, a tricuspid ring 50 of the present invention having a ring body 52 generally arranged about an axis 54 and being discontinuous so as to define two free ends 56 a , 56 b .
- the axis 54 in FIG. 7A lies at the centroid of the ring or along of the axis of blood flow through the ring 50 when implanted, and it will be understood that the relative directions up and down are as viewed in FIG. 7B .
- the ring 50 is designed to be implanted in a tricuspid annulus such that blood will flow in the downward direction.
- the ring body 52 is substantially asymmetric and ovoid with the first free end 56 a located adjacent the antero-septal commissure (see FIG. 3 ).
- the ring body 52 extends in a clockwise direction, as seen looking at the inflow side in FIG.
- the precise relative dimensions of the segments may vary, but they are generally as indicated in the view of FIG. 7A . That is, the second segment 60 b is the largest, followed by the first segment 60 a , and then the smaller third segment 60 c and fourth segment 60 d . It should be further noted that the term “asymmetric” means that there are no planes of symmetry through the ring body 52 looking from the inflow side, and “ovoid” means generally shaped like an egg with a long axis and a short axis, and one long end larger than the other.
- FIG. 8 shows the tricuspid ring 50 in plan view after having been implanted or otherwise affixed to a tricuspid valve.
- the combined first and second segments 60 a and 60 b extend approximately around the tricuspid annulus between the two commissures 28 that bookend the septal leaflet 24 a .
- a pair of commissure markers 62 a , 62 b on the exterior of the ring body 52 facilitate implantation by registering the ring 50 with respect to the commissures 28 .
- the markers 62 a , 62 b are typically radially-oriented colored thread fastened to a fabric covering on the ring.
- a majority of the ring body 52 is planar except for the free ends 56 a , 56 b which are upturned and the first segment 60 a and a part of fourth segment 60 d that are bowed upward. (To repeat, the “up” direction is merely for purpose of clarity herein and is synonymous with the inflow direction).
- sizes 26 mm through 36 mm in 2 mm increments are available having outside diameters (OD) between 31.2-41.2 mm, and inside diameters (ID) between 24.3-34.3 mm. Again, these diameters are taken along the “diametric” line spanning the greatest length across the ring, as seen in FIG. 5A . It should be mentioned that the present invention is not limited to the aforementioned range of sizes, and larger rings of 38 or 40 mm OD are also possible, for example.
- a gap G′ between the two free ends 56 a , 56 b is substantially larger than in certain rings of the prior art to reduce the risk of suturing into the AV node or bundle of His, and to accommodate variations in anatomy and location of the bundle of His.
- the gap G′ is preferably between about 40%-50% of the labeled size, preferably between about 43-45%.
- the gap G′ is about 40% of the size of the long axis of the ring, which is typically the labeled size in millimeters.
- the gap G′ is desirably between about 10-18 mm, depending on the labeled size.
- the gap G′ is preferably about 13.6 mm for a size 34 ring (about 40% of the labeled size).
- the gap G′ is not too large to reduce the effective support for the septal leaflet 24 a .
- the fourth segment 60 d of the ring 50 of the present invention extends at least half of the way around the septal leaflet 24 a.
- the gap G′ is larger than the gap G in the rigid C-shaped Carpentier-Edwards Classic® Tricuspid Annuloplasty Ring, seen in FIGS. 5A and 5B .
- the gap G for the various sizes of Classic® Rings ranges between about 5-8 mm, or between about 19%-22% of the labeled size.
- the gap G′ of the ring of the present invention is larger than the gap in the flexible C-shaped SoveringTM tricuspid ring from Sorin Biomedica Cardio S.p.A.
- the gap for the various sizes of the SoveringTM ranges between about 18-24 mm, or between about 60%-70% of the labeled size.
- the gap G′ of the ring of the present invention is preferably greater than 8 mm and less than 18 mm, or is between about 23%-59% of the labeled size (typically equal to the dimension in millimeters of the long axis of the ring).
- the free ends 56 a , 56 b of the exemplary ring 50 are upturned in the inflow direction so as to help reduce abrasion on the adjacent leaflets (septal, or both septal and antero-superior).
- Prior rings that are not completely flexible terminate in ends that are extensions of the ring periphery, that is, they do not deviate from the paths that the adjacent segments of the ring follow.
- the present ring 50 desirably includes a core member that provides at least some rigidity and structural support for the annulus.
- the upturned ends 56 a , 56 b present curved surfaces that the constantly moving leaflets might repeatedly contact, as opposed to point surfaces so that forcible abrasion of the moving leaflets in contact with the ends of the ring is avoided.
- the exemplary ring 50 also includes an upward arcuate bow or bulge 64 in the first segment 60 a , and another upward bulge 65 in the fourth segment 60 d .
- the “aortic” bulge 64 accommodates a similar contour of the tricuspid annulus due to the external presence of the aorta and desirably extends from near the first free end 56 a along first segment 60 a to a location that corresponds to the end of the aortic part of the anterior leaflet.
- Prior tricuspid rings are substantially planar, and if at all rigid they necessarily deform the annulus to some extent at this location.
- the aortic bulge 64 helps reduce stress upon implant and concurrently reduces the chance of dehiscence, or the attaching sutures pulling out of the annulus.
- the axial height h b of the aortic bulge 64 above the nominal top surface of the ring body 52 is between about 3-9 mm, preferably about 6 mm.
- the “septal” bulge 65 conforms to the slight bulging of the septal leaflet attachment in this area.
- the axial height h s of the septal bulge 65 above the nominal top surface of the ring body 52 is between about 2 to 4 mm.
- the tricuspid ring 50 of the present invention is seen partially cutaway and in sections to illustrate further exemplary features.
- the ring body 52 preferably comprises an inner core 70 encompassed by an elastomeric interface 72 and an outer fabric covering 74 .
- the inner core 70 extends substantially around the entire periphery of the ring body 52 and is a relatively rigid material such as stainless steel, titanium, Elgiloy (an alloy primarily including Ni, Co, and Cr), Nitinol, and even certain polymers.
- the term “relatively rigid” refers to the ability of the core 70 to support the annulus without substantial deformation, and implies a minimum elastic strength that enables the ring to maintain its original shape after implant even though it may flex somewhat. Indeed, as will be apparent, the ring desirably possesses some flexibility around its periphery.
- the core 70 would not be made of silicone, which easily deforms to the shape of the annulus and therefore will not necessarily maintain its original shape upon implant.
- the elastomeric interface 72 may be silicone rubber molded around the core 70 , or a similar expedient.
- the elastomeric interface 72 provides bulk to the ring for ease of handling and implant, and permits passage of sutures though not significantly adding to the anchoring function of the outer fabric covering 74 .
- the fabric covering 74 may be any biocompatible material such as Dacron® (polyethylene terepthalate). As seen in FIGS. 10A-10C , the elastomeric interface 72 and fabric covering 74 project outwards along the outside of the ring 50 to provide a platform through which to pass sutures.
- the ring 50 of the present invention may possess a varying flexibility around its periphery.
- the ring 50 is desirably stiffer adjacent the first free end 56 a than adjacent the second free end 56 b , and preferably has a gradually changing degree of flexibility for at least a portion in between.
- the first segment 60 a may be relatively stiff while the remainder of the ring body 52 gradually becomes more flexible through the second segment 60 b , third segment 60 c , and fourth segment 60 d .
- the fourth segment 60 d is more flexible than the third segment 60 c.
- the flexibility of the fourth segment 60 d accommodates the inward movement of the annulus in that sector from fluid dynamic closing forces on the valve, and therefore reduces the chance of dehiscence. More particularly, radial forces exerted on the ring in the vertical direction, or along the small axis, will act on the flexible fourth segment 60 d and proportionately bend it inward, as indicated in phantom. This reduction in the antero-septal ring dimension, in turn, will reduce tension on the native valve leaflets that pull inward from valve closing forces. Tests have been conducted to determine the amount of force and movement associated with the septal aspect of the tricuspid annulus in both systole and diastole.
- the flexibility of the fourth segment 60 d is such that it deforms inward by about 10% of the antero-septal (small axis) ring dimension under maximum load, typically resulting from right ventricular pressures of up to 70 mm Hg.
- left ventricular pressures of up to 120 mm Hg are handled by a more robust mitral annulus.
- the tricuspid annulus is more fragile and implanted annuluplasty rings are somewhat more prone to dehiscence.
- variable flexibility consists of one or more points of localized flexibility, or “hinge points,” that may supplement the aforementioned gradually changing stiffness or be incorporated into an otherwise constant stiffness ring.
- hinge points points of localized flexibility
- the locations of the contemplated hinges are best described with reference to FIGS. 7A and 7B .
- a central hinge created by an area of the ring body 52 that is locally more flexible than adjacent sectors is desirably located mid-way along the second segment 60 b , as indicated by a hinge line 66 .
- This hinge is located approximately at the center of the length of the ring body 52 , and permits the segments on either side to flex or twist with respect to one another.
- two generally diametrically-opposed hinge points indicated by hinge lines 61 and 67 may be provided. These hinges are located at the upward bulges 64 , 65 in the ring body 52 , and provide “saddle” flexibility so that the ring flexes generally in a plane intersecting the bulges.
- a ring according to the present invention may have one or more of these hinges.
- the discrete hinges or points of flexibility may be incorporated into rings having constant or variable flexibility, as described above.
- 3-dimensional rings are shown, the several embodiments of flexibility described herein may also be provided in a flat, planar tricuspid ring, and with or without the increase gap between the free ends.
- the ring body includes a core 70 made of a plurality of concentric peripheral bands having an axial dimension which is larger adjacent the first free end 56 a than adjacent the second free end 56 b .
- Sectional FIGS. 10A-10C illustrate this embodiment.
- the core 70 in the first segment 60 a (and possibly in a portion of the second segment 60 b ) is as seen in FIG. 10A , with six (6) concentric bands of a material such as Elgiloy.
- a section of the core 701 still comprises six concentric bands, but its axial height is reduced relative to the height of the core as seen in FIG. 10A .
- 10C shows a section through the third segment 60 c wherein a further section of the core 70 ′′ is further reduced in height but also only comprises four (4) concentric bands, with two of the bands having terminated or tapered off somewhere between sections 10 B and 10 C.
- this construction is entirely exemplary and the core 70 could also be made of a single integral member that gradually tapers down in size, among other alternatives.
- U.S. Pat. No. 5,104,407 to Lam, et al. the disclosure of which is expressly incorporated herein by reference.
- FIG. 10D shows the internal structure of the ring body 52 at the second end 56 b .
- the core 70 is shown bending upward into close proximity with the extreme tip of the free end 56 b , though it is protected by the elastomeric interface 72 and the outer fabric covering 74 .
- the core 70 has its greatest flexibility at this location, which is mid-way around the septal leaflet side of the tricuspid annulus.
- the upward bend of the core 70 and ring body 52 desirably makes an angle ⁇ of between 45°-90°, preferably greater than 60°.
- the axial height h e as indicated in FIG.
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
Abstract
A prosthetic tricuspid remodeling annuloplasty ring having two free ends that are upturned in the inflow direction to help avoid unnecessary leaflet abrasion. The free ends are desirably separated across a gap that is large enough to reduce the risk of passing sutures through the conductive system of the heart, yet not too large that support of the septal leaflet of the tricuspid annulus is degraded. The tricuspid ring may have four sequential segments looking from the inflow side and extending in a clockwise direction from a free end located adjacent the antero septal commissure after implant. The ring may define an inflow bulge in the first segment and/or an inflow bulge in the fourth segment that help the ring conform to the natural bulges created by the adjacent aorta, thereby reducing stress and the potential for ring dehiscence. Desirably, the ring has variable flexibility, either gradual and/or between or within different segments, so as to adapt or harmonize its 3-dimensional shape to each individual patient and, therefore, to significantly reduce the constraints on the annulus and adjacent structures, particularly the leaflets and the conduction tissue.
Description
- The present invention relates generally to medical devices and particularly to a tricuspid annuloplasty ring.
- In vertebrate animals, the heart is a hollow muscular organ having four pumping chambers: the left and right atria and the left and right ventricles, each provided with its own one-way valve. The natural heart valves are identified as the aortic, mitral (or bicuspid), tricuspid and pulmonary, and are each mounted in an annulus comprising dense fibrous rings attached either directly or indirectly to the atrial and ventricular muscle fibers. Each annulus defines a flow orifice.
- Heart valve disease is a widespread condition in which one or more of the valves of the heart fails to function properly. Diseased heart valves may be categorized as either stenotic, wherein the valve does not open sufficiently to allow adequate forward flow of blood through the valve, and/or incompetent, wherein the valve does not close completely, causing excessive backward flow of blood through the valve when the valve is closed. Valve disease can be severely debilitating and even fatal if left untreated.
- Various surgical techniques may be used to repair a diseased or damaged valve. In a valve replacement operation, the damaged leaflets are excised and the annulus sculpted to receive a replacement valve. Another less drastic method for treating defective valves is through repair or reconstruction, which is typically used on minimally calcified valves. The most widely used repair technique is remodeling annuloplasty first proposed by the same inventor in which the deformed valve annulus is reshaped by attaching a prosthetic annuloplasty repair segment or ring to the valve annulus. The annuloplasty ring is designed to support the functional changes that occur during the cardiac cycle: maintaining coaptation and valve integrity to prevent reverse flow while permitting good hemodynamics during forward flow.
- The present invention relates generally to medical devices and particularly to a tricuspid annuloplasty ring.
- In vertebrate animals, the heart is a hollow muscular organ having four pumping chambers: the left and right atria and the left and right ventricles, each provided with its own one-way valve. The natural heart valves are identified as the aortic, mitral (or bicuspid), tricuspid and pulmonary, and are each mounted in an annulus comprising dense fibrous rings attached either directly or indirectly to the atrial and ventricular muscle fibers. Each annulus defines a flow orifice.
- Heart valve disease is a widespread condition in which one or more of the valves of the heart fails to function properly. Diseased heart valves may be categorized as either stenotic, wherein the valve does not open sufficiently to allow adequate forward flow of blood through the valve, and/or incompetent, wherein the valve does not close completely, causing excessive backward flow of blood through the valve when the valve is closed. Valve disease can be severely debilitating and even fatal if left untreated.
- Various surgical techniques may be used to repair a diseased or damaged valve. In a valve replacement operation, the damaged leaflets are excised and the annulus sculpted to receive a replacement valve. Another less drastic method for treating defective valves is through repair or reconstruction, which is typically used on minimally calcified valves. The most widely used repair technique is remodeling annuloplasty first proposed by the same inventor in which the deformed valve annulus is reshaped by attaching a prosthetic annuloplasty repair segment or ring to the valve annulus. The annuloplasty ring is designed to support the functional changes that occur during the cardiac cycle: maintaining coaptation and valve integrity to prevent reverse flow while permitting good hemodynamics during forward flow.
- The annuloplasty ring typically comprises an inner substrate of a metal such as rods or bands of stainless steel or titanium, or a flexible material such as silicone rubber or Dacron cordage, covered with a biocompatible fabric or cloth to allow the ring to be sutured to the fibrous annulus tissue. Annuloplasty rings may be stiff or flexible, split or continuous, and may have a variety of shapes, including circular, U-shaped, C-shaped, or kidney-shaped. Examples are seen in U.S. Pat. Nos. 5,041,130, 5,104,407, 5,201,880, 5,258,021, 5,607,471 and, 6,187,040 B1. Whether totally flexible, rigid, or semi-rigid, annuloplasty rings have sometimes been associated with a certain degree of arrhythmia or a 10% to 15% incidence at 10 years of ring dehiscence and/or conduction tissue disturbance. The present invention is intended to reduce the complications.
- For the purposes of anatomic orientation, please refer to
FIG. 1 , which is a schematic representation of the AV junctions within the heart and the body in the left anterior oblique projection. The body is viewed in the upright position and has 3 orthogonal axes: superior-inferior, posterior-anterior, and right-left. Traditional nomenclature for the AV junctions derives from a surgically distorted view, placing the valvular rings in a single horizontal plane with antero-posterior and right-left lateral coordinates. The descriptive terms used, however, are anatomically inaccurate. An accurate account of the coordinates of the valvular orifices is provided by the simple expedient of relating appropriately the view obtained in left anterior oblique projection to the supero-inferior and antero-posterior coordinates of the body. -
FIG. 2 is a cutaway view of the heart from the front, or anterior, perspective, with most of the primary structures marked. As is well known, the pathway of blood in the heart is from the right atrium to the right ventricle through the tricuspid valve, to and from the lungs, and from the left atrium to the left ventricle through the mitral valve. The present application has particular relevance to the repair of the tricuspid valve, which regulates blood flow between the right atrium and right ventricle, although certain aspects may apply to repair of other of the heart valves. The tricuspid and mitral valves together define the atrioventricular (AV) junctions. - As seen in
FIG. 2 , four structures embedded in the wall of the heart conduct impulses through the cardiac muscle to cause first the atria then the ventricles to contract. These structures are the sinoatrial node (SA node), the atrioventricular node (AV node), the bundle of His, and the Purkinje fibers. On the rear wall of the right atrium is a barely visible knot of tissue known as the sinoatrial, or SA node. This tiny area is the control of the heart's pacemaker mechanism. Impulse conduction normally starts in the SA node. It generates a brief electrical impulse of low intensity approximately 72 times every minute in a resting adult. From this point the impulse spreads out over the sheets of tissue that make up the two atria, exciting the muscle fibers as it does so. This causes contraction of the two atria and thereby thrusts the blood into the empty ventricles. The impulse quickly reaches another small specialized knot of tissue known as the atrioventricular, or AV node, located between the atria and the ventricles. This node delays the impulse for about 0.07 seconds, which is exactly enough time to allow the atria to complete their contractions. When the impulses reach the AV node, they are relayed by way of the several bundles of His and Purkinje fibers to the ventricles, causing them to contract. As those of skill in the art are aware, the integrity and proper functioning of the conductive system of the heart is critical for good health. -
FIG. 3 is a schematic view of the tricuspid valve orifice seen from its inflow side (from the right atrium), with the peripheral landmarks labeled as: antero septal commissure, anterior leaflet, posterior commissure, posterior leaflet, postero septal commissure, and septal leaflet. Contrary to traditional orientation nomenclature, the tricuspid valve is nearly vertical, as reflected by these sector markings. From the same viewpoint, thetricuspid valve 20 is shown surgically exposed inFIG. 4 with anannulus 22 and threeleaflets tendineae 26 connect the leaflets to papillary muscles located in the RV to control the movement of the leaflets. Thetricuspid annulus 22 is an ovoid-shaped fibrous ring at the base of the valve that is less prominent than the mitral annulus, but larger in circumference. - Reflecting their true anatomic location, the three leaflets in
FIG. 4 are identified as septal 24 a, anterior 24 b, and posterior (or “mural”) 24 c. The leaflets join together over three prominent zones of apposition, and the peripheral intersections of these zones are usually described ascommissures 28. The leaflets 24 are tethered at thecommissures 28 by the fan-shaped chordae tendineae 26 arising from prominent papillary muscles originating in the right ventricle. Theseptal leaflet 24 a is the site of attachment to the fibrous trigone, the fibrous “skeletal” structure within the heart. Theanterior leaflet 24 b, largest of the 3 leaflets, often has notches. Theposterior leaflet 24 c, smallest of the 3 leaflets, usually is scalloped. - The
ostium 30 of the right coronary sinus opens into the right atrium, and the tendon ofTodaro 32 extends adjacent thereto. TheAV node 34 and the beginning of the bundle of His 36 are located in the supero-septal region of the tricuspid valve circumference. TheAV node 34 is situated directly on the right atrial side of the central fibrous body in the muscular portion of the AV septum, just superior and anterior to theostium 30 of thecoronary sinus 30. Measuring approximately 1.0 mm×3.0 mm×6.0 mm, the node is flat and oval. TheAV node 34 is located at the apex of the triangle ofKoch 38, which is formed by thetricuspid annulus 22, theostium 30 of the coronary sinus, and the tendon ofTodaro 32. TheAV node 34 continues on to the bundle of His 36, typically via a course inferior to thecommissure 28 between the septal 24 a and anterior 24 b leaflets of the tricuspid valve; however, the precise course of the bundle of His 36 in the vicinity of the tricuspid valve may vary. Moreover, the location of the bundle of His 36 may not be readily apparent from a resected view of the right atrium because it lies beneath the annulus tissue. - The triangle of
Koch 30 and tendon ofTodaro 32 provide anatomic landmarks during tricuspid valve repair procedures. A major factor to consider during surgery is the proximity of the conduction system (AV node 34 and bundle of His 36) to theseptal leaflet 24 a. Of course, surgeons must avoid placing sutures too close to or within theAV node 34. C-shaped rings are good choices for tricuspid valve repairs because they allow surgeons to position the break in the ring adjacent theAV node 34, thus avoiding the need for suturing at that location. - A rigid C-shaped ring of the prior art is the Carpentier-Edwards Classic® Tricuspid Annuloplasty Ring sold by Edwards Lifesciences Corporation of Irvine, Calif., which is seen in
FIGS. 5A and 5B . Although not shown, theplanar ring 40 has an inner titanium core (not shown) covered by a layer of silicone and fabric. Rings forsizes 26 mm through 36 mm in 2 mm increments have outside diameters (OD) between 31.2-41.2 mm, and inside diameters (ID) between 24.3-34.3 mm. These diameters are taken along the “diametric” line spanning the greatest length across the ring because that is the conventional sizing parameter. A gap G between free ends 42 a, 42 b in each provides the discontinuity to avoid attachment over theAV node 34. The gap G for the various sizes ranges between about 5-8 mm, or between about 19%-22% of the labeled size. As seen in the implanted view ofFIG. 6 , the gap G is sized just larger than theAV node 34. Despite this clearance, some surgeons are uncomfortable passing sutures so close to theconductive AV node 34, particularly considering the additional concern of the bundle of His 36. - A flexible C-shaped tricuspid ring is sold under the name Sovering™ by Sorin Biomedica Cardio S.p.A. of Via Crescentino, Italy. The Sovering™ is made with a radiopaque silicone core covered with a knitted polyester (PET) fabric so as to be totally flexible. Rings for
sizes 28 mm through 36 mm in 2 mm increments have outside diameters (OD) between 33.8-41.8 mm, and inside diameters (ID) between 27.8-35.8 mm. As with other tricuspid rings, a gap between the free ends provides a discontinuity to avoid attachment over the AV node. The gap for the various sizes ranges of the Sovering™ ranges between about 18-24 mm, or between about 60%-70% of the labeled size. Although this gap helps avoid passing sutures close to theconductive AV node 34 and bundle of His 36, the ring is designed to be attached at the commissures on either side of the septal leaflet and thus no support is provided on the septal side. - Despite numerous designs presently available or proposed in the past, there is a need for a prosthetic tricuspid ring that better harmonizes with the anatomical and physiologic features of the tricuspid annulus, and in particular for a prosthetic tricuspid ring that better fits the contours of the tricuspid annulus and presents selective flexibility to reduce the stress in the attachment sutures, while at the same time reduces the risk of inadvertently passing a suture through the critical physiologic structures within the heart that conduct impulses.
- The present invention provides a tricuspid annuloplasty ring including a ring body generally arranged in a plane and about an axis along an inflow-outflow direction, the ring body being discontinuous so as to define a first free end and a second free end separated across a gap, the two free ends being bent out of the plane in an inflow direction. Preferably, the two free ends are flexible and can be bent to have an axial height of between about 1-4 mm out of the plane.
- Preferably, the ring body defines a generally asymmetric ovoid shape and extends in a clockwise direction from a first free end located adjacent the antero-septal commissure when implanted, as seen looking at the inflow side thereof, around a first segment, a second segment, a third segment, and a fourth segment that terminates in the second free end at a septal point. In one embodiment the ring body has an arcuate bulge out of the plane toward the inflow side at the first segment to accommodate an anatomical bulge of the aorta into the tricuspid annulus. In a further embodiment, the ring body has an arcuate bulge out of the plane toward the inflow side at the fourth segment to accommodate an anatomical bulge of the aorta into the tricuspid annulus. Still further, the ring body desirably has a varying flexibility and is stiffer adjacent the first free end than adjacent the second free end, or comprises at least one hinge point that is locally more flexible than adjacent segments. In one preferred construction, the ring body comprises a plurality of concentric peripheral bands having an axial dimension which is larger adjacent the first free end than adjacent the second free end. In a preferred embodiment, the ring has a long dimension in millimeters, and the free ends are separated by a distance of between about 40%-50% of the long dimension.
- In accordance with another aspect of the invention, a prosthetic tricuspid annuloplasty ring having a long dimension in millimeters, comprises an asymmetric generally ovoid ring body. The ring body is generally arranged in a plane and about an axis along an inflow-outflow direction and is discontinuous so as to define two free ends. The ring body has a length and shape such that if a first free end is implanted adjacent an antero septal commissure of the tricuspid annulus, the ring body conforms to the tricuspid annulus and a second end is located adjacent a septal leaflet thereof, and the free ends are separated across a gap having a dimension of between about 40%-50% of the long dimension.
- In the ring having a gap of between 40%-50% of the long dimension, the ring body extends in a clockwise direction from the first free end, as seen looking at the inflow side thereof around a first segment, a second segment, a third segment, and a fourth segment that terminates in the second free end at a septal point. In one embodiment the ring body has an arcuate bulge out of the plane toward the inflow side at the first segment to accommodate an anatomical bulge of the aorta into the tricuspid annulus. In a further embodiment, the ring body has an arcuate bulge out of the plane toward the inflow side at the fourth segment. Still further, the ring body desirably has a varying flexibility and is stiffer adjacent the first free end than adjacent the second free end, or comprises at least one hinge point that is locally more flexible than adjacent segments.
- In accordance with a still further aspect of the invention, a prosthetic tricuspid annuloplasty ring comprises an asymmetric generally ovoid ring body generally arranged in a plane and about an axis along an inflow-outflow direction with a first free end located adjacent an antero-septal commissure when implanted and a second free end located at a septal point. The ring body extends in a clockwise direction as seen looking at an inflow side from the first free end around a first segment, a second segment, a third segment, and a fourth segment that terminates in the second free end. The ring body has an arcuate bulge out of the plane toward the inflow side at the first segment so as to accommodate an anatomical bulge of the aorta into the tricuspid annulus. The ring body may also have an arcuate bulge out of the plane toward the inflow side at the fourth segment. Desirably, the ring body has a varying flexibility and the fourth segment is relatively more flexible than the third segment. The first free end may also be stiffer than the second free end. Alternatively, the varying flexibility comprises at least one hinge point that is locally more flexible than adjacent segments.
- In a further embodiment, and prosthetic tricuspid annuloplasty ring is provided that comprises an asymmetric generally ovoid ring body generally arranged in a plane and about an axis along an inflow-outflow direction with a first free end located adjacent an antero-septal commissure when implanted and a second free end located at a septal point. The ring body extends in a clockwise direction as seen looking at an inflow side from the first free end around a first segment, an second segment, a third segment, and a fourth segment that terminates in the second free end. The ring body has a variable flexibility comprising at least one hinge point that is locally more flexible than adjacent segments. Desirably, the hinge point is located at the approximate midpoint of the ring body. Alternatively, there are two hinge points located approximately diametrically opposite one another so that the ring flexes generally in a plane.
- A further understanding of the nature and advantages of the invention will become apparent by reference to the remaining portions of the specification and drawings.
- Features and advantages of the present invention will become appreciated as the same become better understood with reference to the specification, claims, and appended drawings wherein:
-
FIG. 1 is a schematic representation of the AV junctions within the heart and the body in the left anterior oblique projection; -
FIG. 2 is a cutaway view of the heart from the front, or anterior, perspective; -
FIG. 3 is a schematic plan view of the tricuspid annulus with typical orientation directions noted as seen from the inflow side; -
FIG. 4 is a plan view of the native tricuspid valve and surrounding anatomy from the inflow side; -
FIGS. 5A and 5B are plan and septal elevational views, respectively, of a planar tricuspid annuloplasty ring of the prior art; -
FIG. 6 is a plan view of the native tricuspid valve and surrounding anatomy from the inflow side with the annuloplasty ring ofFIGS. 5A-5B implanted; -
FIGS. 7A-7C are plan and septal and anterior elevational views, respectively, of an exemplary tricuspid annuloplasty ring of the present invention illustrating its free ends bent toward the inflow side and an antero-superior bulge; -
FIG. 8 is a plan view of the native tricuspid valve and surrounding anatomy from the inflow side with the annuloplasty ring ofFIGS. 7A-7B implanted; -
FIGS. 9A-9C are plan and septal and anterior elevational views, respectively, of the exemplary tricuspid annuloplasty ring ofFIGS. 7A-7B with portions cutaway to show internal details; and -
FIGS. 10A-10D are sectional views taken along respective section lines inFIG. 9A . - The present invention provides an improved tricuspid annuloplasty ring that better conforms to the native annulus and is shaped to protect certain features of the surrounding anatomy. The ring of the present invention is designed to support a majority of the tricuspid annulus without risking injury to the leaflet tissue and heart's conductive system, such as the
AV node 34 and bundle of His 36 (seeFIG. 4 ). Additionally, the present ring is contoured to better approximate the three-dimensional shape of the tricuspid annulus; specifically, the ring is substantially planar but includes a bulge in the inflow direction at the location of the bulge created by the adjacent aorta. The bulge helps reduce stress between the ring and surrounding tissue, and thus the potential for tearing or ring dehiscence. - Another feature that matches the present tricuspid ring with the physiological features of the annulus is a variable flexibility from a relatively stiff first segment to a relatively flexible fourth segment. This varying flexibility permits the ring to adapt (harmonize) its motion and 3-dimensional shape to that of the annulus, rather than impose its own motion and 3-D geometry thereto which tends to increase the risk of ring dehiscence. In particular, the motion of the tricuspid annulus during systole-diastole is believed to exert some torsional forces on the implanted ring, and the variable flexibility accommodates such torques. Moreover, localized points of flexibility or “hinges” around the ring as described herein may best conform and harmonize the physical properties of the ring to the annulus motion, while at the same time providing the needed corrective support.
- It should also be understood that certain features of the present tricuspid ring might also be applicable and beneficial to rings for other of the heart's annuluses. For instance, the present ring includes upturned or bent free ends that help reduce abrasion on the adjacent leaflets. The same structure might be used in a discontinuous ring for the mitral valve annulus.
- The term “axis” in reference to the illustrated ring, and other non-circular or non-planar rings, refers to a line generally perpendicular to the ring that passes through the area centroid of the ring when viewed in plan view. “Axial” or the direction of the “axis” can also be viewed as being parallel to the direction of blood flow within the valve orifice and thus within the ring when implanted therein. Stated another way, the implanted tricuspid ring orients about a central flow axis aligned along an average direction of blood flow through the tricuspid annulus. Although the rings of the present invention are 3-dimensional, portions thereof are planar and lie perpendicular to the flow axis.
-
FIGS. 7A-7C illustrate, in plan and septal and anterior elevational views, atricuspid ring 50 of the present invention having aring body 52 generally arranged about anaxis 54 and being discontinuous so as to define twofree ends axis 54 inFIG. 7A lies at the centroid of the ring or along of the axis of blood flow through thering 50 when implanted, and it will be understood that the relative directions up and down are as viewed inFIG. 7B . Using this convention, thering 50 is designed to be implanted in a tricuspid annulus such that blood will flow in the downward direction. - As seen in
FIGS. 7A-7C and also inFIGS. 9A-9C , thering body 52 is substantially asymmetric and ovoid with the firstfree end 56 a located adjacent the antero-septal commissure (seeFIG. 3 ). Thering body 52 extends in a clockwise direction, as seen looking at the inflow side inFIG. 7A , around afirst segment 60 a corresponding to the aortic part of the anterior leaflet, asecond segment 60 b corresponding to the remaining part of the anterior leaflet and ending at the postero septal commissure, athird segment 60 c from the postero septal commissure to aline 61 part way along the septal leaflet, and afourth segment 60 d that terminates in the secondfree end 56 b at a septal point. The nomenclature for these segments is taken from the standard anatomical nomenclature around the tricuspid annulus as seen inFIG. 3 . - The precise relative dimensions of the segments may vary, but they are generally as indicated in the view of
FIG. 7A . That is, thesecond segment 60 b is the largest, followed by thefirst segment 60 a, and then the smallerthird segment 60 c andfourth segment 60 d. It should be further noted that the term “asymmetric” means that there are no planes of symmetry through thering body 52 looking from the inflow side, and “ovoid” means generally shaped like an egg with a long axis and a short axis, and one long end larger than the other. -
FIG. 8 shows thetricuspid ring 50 in plan view after having been implanted or otherwise affixed to a tricuspid valve. To quantify relative to the native anatomy, the combined first andsecond segments commissures 28 that bookend theseptal leaflet 24 a. Accordingly, a pair ofcommissure markers ring body 52 facilitate implantation by registering thering 50 with respect to thecommissures 28. Themarkers - A majority of the
ring body 52 is planar except for the free ends 56 a, 56 b which are upturned and thefirst segment 60 a and a part offourth segment 60 d that are bowed upward. (To repeat, the “up” direction is merely for purpose of clarity herein and is synonymous with the inflow direction). As with existing rings,sizes 26 mm through 36 mm in 2 mm increments are available having outside diameters (OD) between 31.2-41.2 mm, and inside diameters (ID) between 24.3-34.3 mm. Again, these diameters are taken along the “diametric” line spanning the greatest length across the ring, as seen inFIG. 5A . It should be mentioned that the present invention is not limited to the aforementioned range of sizes, and larger rings of 38 or 40 mm OD are also possible, for example. - A gap G′ between the two
free ends size 34 ring (about 40% of the labeled size). On the other hand, the gap G′ is not too large to reduce the effective support for theseptal leaflet 24 a. Preferably, thefourth segment 60 d of thering 50 of the present invention extends at least half of the way around theseptal leaflet 24 a. - In a preferred embodiment, the gap G′ is larger than the gap G in the rigid C-shaped Carpentier-Edwards Classic® Tricuspid Annuloplasty Ring, seen in
FIGS. 5A and 5B . The gap G for the various sizes of Classic® Rings ranges between about 5-8 mm, or between about 19%-22% of the labeled size. At the same time, the gap G′ of the ring of the present invention is larger than the gap in the flexible C-shaped Sovering™ tricuspid ring from Sorin Biomedica Cardio S.p.A. The gap for the various sizes of the Sovering™ ranges between about 18-24 mm, or between about 60%-70% of the labeled size. Therefore, the gap G′ of the ring of the present invention is preferably greater than 8 mm and less than 18 mm, or is between about 23%-59% of the labeled size (typically equal to the dimension in millimeters of the long axis of the ring). - The free ends 56 a, 56 b of the
exemplary ring 50 are upturned in the inflow direction so as to help reduce abrasion on the adjacent leaflets (septal, or both septal and antero-superior). Prior rings that are not completely flexible terminate in ends that are extensions of the ring periphery, that is, they do not deviate from the paths that the adjacent segments of the ring follow. As will be explained below, thepresent ring 50 desirably includes a core member that provides at least some rigidity and structural support for the annulus. The upturned ends 56 a, 56 b present curved surfaces that the constantly moving leaflets might repeatedly contact, as opposed to point surfaces so that forcible abrasion of the moving leaflets in contact with the ends of the ring is avoided. - As seen in
FIGS. 7B and 7C , theexemplary ring 50 also includes an upward arcuate bow orbulge 64 in thefirst segment 60 a, and anotherupward bulge 65 in thefourth segment 60 d. The “aortic”bulge 64 accommodates a similar contour of the tricuspid annulus due to the external presence of the aorta and desirably extends from near the firstfree end 56 a alongfirst segment 60 a to a location that corresponds to the end of the aortic part of the anterior leaflet. Prior tricuspid rings are substantially planar, and if at all rigid they necessarily deform the annulus to some extent at this location. Theaortic bulge 64 helps reduce stress upon implant and concurrently reduces the chance of dehiscence, or the attaching sutures pulling out of the annulus. The axial height hb of theaortic bulge 64 above the nominal top surface of thering body 52, as indicated inFIG. 9C , is between about 3-9 mm, preferably about 6 mm. The “septal”bulge 65 conforms to the slight bulging of the septal leaflet attachment in this area. The axial height hs of theseptal bulge 65 above the nominal top surface of thering body 52, as indicated inFIG. 9B , is between about 2 to 4 mm. These twobulges ring body 52. - Now with particular reference to
FIGS. 9A-9C and 10A-10D, thetricuspid ring 50 of the present invention is seen partially cutaway and in sections to illustrate further exemplary features. As seen best in the cutaway portion ofFIG. 9B , thering body 52 preferably comprises aninner core 70 encompassed by anelastomeric interface 72 and an outer fabric covering 74. - The
inner core 70 extends substantially around the entire periphery of thering body 52 and is a relatively rigid material such as stainless steel, titanium, Elgiloy (an alloy primarily including Ni, Co, and Cr), Nitinol, and even certain polymers. The term “relatively rigid” refers to the ability of the core 70 to support the annulus without substantial deformation, and implies a minimum elastic strength that enables the ring to maintain its original shape after implant even though it may flex somewhat. Indeed, as will be apparent, the ring desirably possesses some flexibility around its periphery. To further elaborate, thecore 70 would not be made of silicone, which easily deforms to the shape of the annulus and therefore will not necessarily maintain its original shape upon implant. - The
elastomeric interface 72 may be silicone rubber molded around thecore 70, or a similar expedient. Theelastomeric interface 72 provides bulk to the ring for ease of handling and implant, and permits passage of sutures though not significantly adding to the anchoring function of the outer fabric covering 74. The fabric covering 74 may be any biocompatible material such as Dacron® (polyethylene terepthalate). As seen inFIGS. 10A-10C , theelastomeric interface 72 and fabric covering 74 project outwards along the outside of thering 50 to provide a platform through which to pass sutures. - As mentioned above, the
ring 50 of the present invention may possess a varying flexibility around its periphery. In general, thering 50 is desirably stiffer adjacent the firstfree end 56 a than adjacent the secondfree end 56 b, and preferably has a gradually changing degree of flexibility for at least a portion in between. For instance, thefirst segment 60 a may be relatively stiff while the remainder of thering body 52 gradually becomes more flexible through thesecond segment 60 b,third segment 60 c, andfourth segment 60 d. In a preferred embodiment, thefourth segment 60 d is more flexible than thethird segment 60 c. - With reference to
FIG. 7A , the reader will appreciate that the flexibility of thefourth segment 60 d accommodates the inward movement of the annulus in that sector from fluid dynamic closing forces on the valve, and therefore reduces the chance of dehiscence. More particularly, radial forces exerted on the ring in the vertical direction, or along the small axis, will act on the flexiblefourth segment 60 d and proportionately bend it inward, as indicated in phantom. This reduction in the antero-septal ring dimension, in turn, will reduce tension on the native valve leaflets that pull inward from valve closing forces. Tests have been conducted to determine the amount of force and movement associated with the septal aspect of the tricuspid annulus in both systole and diastole. Consequently, a preferred flexibility for thefourth segment 60 d has been determined and quantified in terms of the amount of desirable deformation under a given load. In one embodiment, the flexibility of thefourth segment 60 d is such that it deforms inward by about 10% of the antero-septal (small axis) ring dimension under maximum load, typically resulting from right ventricular pressures of up to 70 mm Hg. In contrast, left ventricular pressures of up to 120 mm Hg are handled by a more robust mitral annulus. The tricuspid annulus is more fragile and implanted annuluplasty rings are somewhat more prone to dehiscence. - Another potential configuration of variable flexibility consists of one or more points of localized flexibility, or “hinge points,” that may supplement the aforementioned gradually changing stiffness or be incorporated into an otherwise constant stiffness ring. The locations of the contemplated hinges are best described with reference to
FIGS. 7A and 7B . - A central hinge created by an area of the
ring body 52 that is locally more flexible than adjacent sectors is desirably located mid-way along thesecond segment 60 b, as indicated by ahinge line 66. This hinge is located approximately at the center of the length of thering body 52, and permits the segments on either side to flex or twist with respect to one another. Alternatively, two generally diametrically-opposed hinge points indicated byhinge lines upward bulges ring body 52, and provide “saddle” flexibility so that the ring flexes generally in a plane intersecting the bulges. A ring according to the present invention may have one or more of these hinges. Also, as mentioned above, the discrete hinges or points of flexibility may be incorporated into rings having constant or variable flexibility, as described above. Finally, though 3-dimensional rings are shown, the several embodiments of flexibility described herein may also be provided in a flat, planar tricuspid ring, and with or without the increase gap between the free ends. - In one exemplary construction, the ring body includes a core 70 made of a plurality of concentric peripheral bands having an axial dimension which is larger adjacent the first
free end 56 a than adjacent the secondfree end 56 b. SectionalFIGS. 10A-10C illustrate this embodiment. The core 70 in thefirst segment 60 a (and possibly in a portion of thesecond segment 60 b) is as seen inFIG. 10A , with six (6) concentric bands of a material such as Elgiloy. In the section ofFIG. 10B , which is taken through thesecond segment 60 b, a section of the core 701 still comprises six concentric bands, but its axial height is reduced relative to the height of the core as seen inFIG. 10A . Finally,FIG. 10C shows a section through thethird segment 60 c wherein a further section of the core 70″ is further reduced in height but also only comprises four (4) concentric bands, with two of the bands having terminated or tapered off somewhere betweensections -
FIG. 10D shows the internal structure of thering body 52 at thesecond end 56 b. Thecore 70 is shown bending upward into close proximity with the extreme tip of thefree end 56 b, though it is protected by theelastomeric interface 72 and the outer fabric covering 74. Desirably, thecore 70 has its greatest flexibility at this location, which is mid-way around the septal leaflet side of the tricuspid annulus. The upward bend of thecore 70 andring body 52 desirably makes an angle θ of between 45°-90°, preferably greater than 60°. Furthermore, the axial height he, as indicated inFIG. 9C , of the free ends 56 a, 56 b above the nominal top surface of thering body 52 is between about 1-4 mm, preferably about 2 mm, and preferably the two free ends project upward the same distance (although such a configuration is not an absolute requirement). Because of the flexibility of thering body 52 at thesecond end 56 b, there is a reduction in the antero-septal dimension of the ring depending on the load applied by the annulus in the small axis (vertical) dimension. - While the foregoing is a complete description of the preferred embodiments of the invention, various alternatives, modifications, and equivalents may be used. Moreover, it will be obvious that certain other modifications may be practiced within the scope of the appended claims.
Claims (20)
1. A prosthetic tricuspid annuloplasty ring, comprising:
a ring body generally arranged in a plane and about an axis along an inflow-outflow direction, the ring body being discontinuous so as to define a first free end and a second free end separated across a gap, the two free ends being bent out of the plane in an inflow direction.
2. The prosthetic tricuspid annuloplasty ring of claim 1 , wherein the ring body defines a generally asymmetric ovoid shape and extends in a clockwise direction from a first free end located adjacent the antero-septal commissure when implanted, as seen looking at the inflow side thereof, around a first segment, a second segment, a third segment, and a fourth segment that terminates in the second free end at a septal point, and wherein the ring body has an arcuate bulge out of the plane toward the inflow side at the first segment to accommodate an anatomical bulge of the aorta into the tricuspid annulus.
3. The prosthetic tricuspid annuloplasty ring of claim 1 , wherein the ring body defines a generally asymmetric ovoid shape and extends in a clockwise direction from a first free end located adjacent the antero-septal commissure when implanted, as seen looking at the inflow side thereof, around a first segment, a second segment, a third segment, and a fourth segment that terminates in the second free end at a septal point, and wherein the ring body has an arcuate bulge out of the plane toward the inflow side at the fourth segment.
4. The prosthetic tricuspid annuloplasty ring of claim 1 , wherein the ring body defines a generally asymmetric ovoid shape and extends in a clockwise direction from a first free end located adjacent the antero-septal commissure when implanted, as seen looking at the inflow side thereof, around a first segment, a second segment, a third segment, and a fourth segment that terminates in the second free end at a septal point, and wherein the ring body has a varying flexibility and the fourth segment is relatively more flexible than the third segment.
5. The prosthetic tricuspid annuloplasty ring of claim 1 , wherein the ring body has a varying flexibility and is stiffer adjacent the first free end than adjacent the second free end.
6. The prosthetic tricuspid annuloplasty ring of claim 1 , wherein the ring body has a varying flexibility comprising at least one hinge point that is locally more flexible than adjacent segments.
7. The prosthetic tricuspid annuloplasty ring of claim 1 , wherein the ring has a long dimension in millimeters, and the free ends are separated by a distance of between about 40%-50% of the long dimension.
8. The prosthetic tricuspid annuloplasty ring of claim 1 , wherein the two free ends are each bent to have an axial height of between about 1-4 mm out of the plane.
9. A prosthetic tricuspid annuloplasty ring having a long dimension in millimeters, comprising:
an asymmetric generally ovoid ring body generally arranged in a plane and about an axis along an inflow-outflow direction and being discontinuous so as to define two free ends, the ring body having a length and shape such that if a first free end is implanted adjacent an antero septal commissure of the tricuspid annulus the ring body conforms to the tricuspid annulus and a second end is located adjacent a septal leaflet of the tricuspid annulus, and the free ends are separated across a gap having a dimension of between about 40%-50% of the long dimension.
10. The prosthetic tricuspid annuloplasty ring of claim 9 , wherein the ring body extends in a clockwise direction from the first free end, as seen looking at the inflow side thereof around a first segment, a second segment, a third segment, and a fourth segment that terminates in the second free end at a septal point, and wherein the ring body has an arcuate bulge out of the plane toward the inflow side at the first segment to accommodate an anatomical bulge of the aorta into the tricuspid annulus.
11. The prosthetic tricuspid annuloplasty ring of claim 9 , wherein the ring body extends in a clockwise direction from the first free end, as seen looking at the inflow side thereof, around a first segment, a second segment, a third segment, and a fourth segment that terminates in the second free end at a septal point, and wherein the ring body has an arcuate bulge out of the plane toward the inflow side at the fourth segment.
12. The prosthetic tricuspid annuloplasty ring of claim 9 , wherein the ring body has a varying flexibility and is stiffer adjacent the first free end than adjacent the second free end.
13. The prosthetic tricuspid annuloplasty ring of claim 9 , wherein the ring body has a varying flexibility comprising at least one hinge point that is locally more flexible than adjacent segments.
14. A prosthetic tricuspid annuloplasty ring, comprising:
an asymmetric generally ovoid ring body generally arranged in a plane and about an axis along an inflow-outflow direction with a first free end located adjacent an antero-septal commissure when implanted and a second free end located at a septal point, wherein the ring body extends in a clockwise direction as seen looking at an inflow side from the first free end around a first segment a second segment, a third segment, and a fourth segment that terminates in the second free end, and wherein the ring body has an arcuate bulge out of the plane toward the inflow side at the first segment so as to accommodate an anatomical bulge of the aorta into the tricuspid annulus.
15. The prosthetic tricuspid annuloplasty ring of claim 14 , wherein the ring body an arcuate bulge out of the plane toward the inflow side at the fourth segment.
16. The prosthetic tricuspid annuloplasty ring of claim 14 , wherein the ring body has a varying flexibility and is stiffer adjacent the first free end than adjacent the second free end.
17. The prosthetic tricuspid annuloplasty ring of claim 16 , wherein the ring body has a varying flexibility comprising at least one hinge point that is locally more flexible than adjacent segments.
18. A prosthetic tricuspid annuloplasty ring, comprising:
an asymmetric generally ovoid ring body generally arranged in a plane and about an axis along an inflow-outflow direction with a first free end located adjacent an antero-septal commissure when implanted and a second free end located at a septal point, wherein the ring body extends in a clockwise direction as seen looking at an inflow side from the first free end around a first segment, a second segment, a third segment, and a fourth segment that terminates in the second free end, and wherein the ring body has a variable flexibility comprising at least one hinge point that is locally more flexible than adjacent segments.
19. The prosthetic tricuspid annuloplasty ring of claim 18 , wherein the hinge point is located at the approximate midpoint of the ring body.
20. The prosthetic tricuspid annuloplasty ring of claim 18 , wherein there are two hinge points located approximately diametrically opposite one another so that the ring flexes generally in a plane.
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/120,184 US20090287303A1 (en) | 2008-05-13 | 2008-05-13 | Physiologically harmonized tricuspid annuloplasty ring |
EP08755581.9A EP2306933B1 (en) | 2008-05-13 | 2008-05-15 | Physiologically harmonized tricuspid annuloplasty ring |
CN200880129174.0A CN102088930B (en) | 2008-05-13 | 2008-05-15 | Physiologically harmonized tricuspid annuloplasty ring |
JP2011509457A JP5390598B2 (en) | 2008-05-13 | 2008-05-15 | Physiologically harmonious tricuspid annuloplasty ring |
PCT/US2008/063758 WO2009139776A1 (en) | 2008-05-13 | 2008-05-15 | Physiologically harmonized tricuspid annuloplasty ring |
CA2721143A CA2721143C (en) | 2008-05-13 | 2008-05-15 | Physiologically harmonized tricuspid annuloplasty ring |
US13/600,040 US9937041B2 (en) | 2008-05-13 | 2012-08-30 | Physiologically harmonized tricuspid annuloplasty ring |
US15/941,499 US20180221150A1 (en) | 2008-05-13 | 2018-03-30 | Physiologically harmonized tricuspid annuloplasty ring |
US17/459,211 US11903830B2 (en) | 2008-05-13 | 2021-08-27 | Physiologically harmonized repair of tricuspid valve |
US18/424,397 US20240156597A1 (en) | 2008-05-13 | 2024-01-26 | Physiologically harmonized tricuspid annuloplasty ring |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/120,184 US20090287303A1 (en) | 2008-05-13 | 2008-05-13 | Physiologically harmonized tricuspid annuloplasty ring |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/600,040 Continuation US9937041B2 (en) | 2008-05-13 | 2012-08-30 | Physiologically harmonized tricuspid annuloplasty ring |
Publications (1)
Publication Number | Publication Date |
---|---|
US20090287303A1 true US20090287303A1 (en) | 2009-11-19 |
Family
ID=39590154
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/120,184 Abandoned US20090287303A1 (en) | 2008-05-13 | 2008-05-13 | Physiologically harmonized tricuspid annuloplasty ring |
US13/600,040 Active 2030-11-05 US9937041B2 (en) | 2008-05-13 | 2012-08-30 | Physiologically harmonized tricuspid annuloplasty ring |
US15/941,499 Abandoned US20180221150A1 (en) | 2008-05-13 | 2018-03-30 | Physiologically harmonized tricuspid annuloplasty ring |
US17/459,211 Active 2028-11-12 US11903830B2 (en) | 2008-05-13 | 2021-08-27 | Physiologically harmonized repair of tricuspid valve |
US18/424,397 Pending US20240156597A1 (en) | 2008-05-13 | 2024-01-26 | Physiologically harmonized tricuspid annuloplasty ring |
Family Applications After (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/600,040 Active 2030-11-05 US9937041B2 (en) | 2008-05-13 | 2012-08-30 | Physiologically harmonized tricuspid annuloplasty ring |
US15/941,499 Abandoned US20180221150A1 (en) | 2008-05-13 | 2018-03-30 | Physiologically harmonized tricuspid annuloplasty ring |
US17/459,211 Active 2028-11-12 US11903830B2 (en) | 2008-05-13 | 2021-08-27 | Physiologically harmonized repair of tricuspid valve |
US18/424,397 Pending US20240156597A1 (en) | 2008-05-13 | 2024-01-26 | Physiologically harmonized tricuspid annuloplasty ring |
Country Status (6)
Country | Link |
---|---|
US (5) | US20090287303A1 (en) |
EP (1) | EP2306933B1 (en) |
JP (1) | JP5390598B2 (en) |
CN (1) | CN102088930B (en) |
CA (1) | CA2721143C (en) |
WO (1) | WO2009139776A1 (en) |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080208331A1 (en) * | 2001-08-28 | 2008-08-28 | Edwards Lifesciences Corporation | Annuloplasty ring with offset free ends |
US20080275551A1 (en) * | 2007-05-01 | 2008-11-06 | Edwards Lifesciences Corporation | Inwardly-bowed tricuspid annuloplasty ring |
US20090192605A1 (en) * | 2008-01-25 | 2009-07-30 | Medtronic, Inc. | Sizer Device Having a Plurality of Anterior-Posterior Ratios |
US7879087B2 (en) * | 2006-10-06 | 2011-02-01 | Edwards Lifesciences Corporation | Mitral and tricuspid annuloplasty rings |
US7959673B2 (en) * | 2007-02-09 | 2011-06-14 | Edwards Lifesciences Corporation | Degenerative valvular disease specific annuloplasty rings |
WO2011097251A1 (en) * | 2010-02-03 | 2011-08-11 | Genesee Biomedical, Inc. | Semi-flexible annuloplasty ring |
US20110238169A1 (en) * | 2010-03-23 | 2011-09-29 | Boston Scientific Scimed, Inc. | Annuloplasty device |
US20120136435A1 (en) * | 2010-11-30 | 2012-05-31 | Edwards Lifesciences Corporation | Reduced Dehiscence Annuloplasty Ring |
WO2012152959A1 (en) * | 2011-05-06 | 2012-11-15 | Sarraj Asil Anas | Kit for anuloplasty of the tricuspid valve |
US8915960B2 (en) | 2010-08-31 | 2014-12-23 | Edwards Lifesciences Corporation | Physiologic tricuspid annuloplasty ring |
US9101472B2 (en) | 2007-09-07 | 2015-08-11 | Edwards Lifesciences Corporation | Active holder for annuloplasty ring delivery |
US9149359B2 (en) | 2001-08-28 | 2015-10-06 | Edwards Lifesciences Corporation | Three-dimensional annuloplasty ring |
US9326858B2 (en) | 2010-08-24 | 2016-05-03 | Edwards Lifesciences Corporation | Flexible annuloplasty ring |
US20160361170A1 (en) * | 2015-06-09 | 2016-12-15 | Edwards Lifesciences, Llc | Asymmetric mitral annuloplasty band |
US9687346B2 (en) | 2013-03-14 | 2017-06-27 | Edwards Lifesciences Corporation | Multi-stranded heat set annuloplasty rings |
US9937041B2 (en) | 2008-05-13 | 2018-04-10 | Edwards Lifesciences Corporation | Physiologically harmonized tricuspid annuloplasty ring |
US10166101B2 (en) | 2001-05-17 | 2019-01-01 | Edwards Lifesciences Corporation | Methods for repairing mitral valves |
CN112437650A (en) * | 2018-05-16 | 2021-03-02 | 李米德基金会 | Semi-rigid annuloplasty ring and method of making same |
US20210192836A1 (en) * | 2018-08-30 | 2021-06-24 | Olympus Corporation | Recording device, image observation device, observation system, control method of observation system, and computer-readable recording medium |
US20220202570A1 (en) * | 2019-07-11 | 2022-06-30 | Medtentia International Ltd Oy | Annuloplasty Device |
US11554015B2 (en) | 2018-07-30 | 2023-01-17 | Edwards Lifesciences Corporation | Minimally-invasive low strain annuloplasty ring |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8579964B2 (en) | 2010-05-05 | 2013-11-12 | Neovasc Inc. | Transcatheter mitral valve prosthesis |
US9554897B2 (en) | 2011-04-28 | 2017-01-31 | Neovasc Tiara Inc. | Methods and apparatus for engaging a valve prosthesis with tissue |
US9308087B2 (en) | 2011-04-28 | 2016-04-12 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
EP2591755A1 (en) | 2011-11-12 | 2013-05-15 | Medtentia International Ltd Oy | Device and method for improving fixation of a medical device |
EP2819619B1 (en) | 2012-02-29 | 2019-01-16 | ValCare, Inc. | Percutaneous annuloplasty system with anterior-posterior adjustment |
US9345573B2 (en) | 2012-05-30 | 2016-05-24 | Neovasc Tiara Inc. | Methods and apparatus for loading a prosthesis onto a delivery system |
FR2998166B1 (en) * | 2012-11-16 | 2016-02-26 | Engin Oder | ANNULAR PROSTHESIS FOR MUNTAL VALVE THERAPY BY ANNULO-PLASTIE |
CN104000670B (en) * | 2013-02-27 | 2016-12-28 | 金仕生物科技(常熟)有限公司 | Adjustable artificial valve's ring |
US9572665B2 (en) | 2013-04-04 | 2017-02-21 | Neovasc Tiara Inc. | Methods and apparatus for delivering a prosthetic valve to a beating heart |
CN104010593B (en) * | 2013-07-29 | 2016-05-25 | 金仕生物科技(常熟)有限公司 | Artificial heart valve forming ring |
CA2927902A1 (en) * | 2013-10-25 | 2015-04-30 | Kephalios S.A.S. | Adjustable annuloplasty ring and system |
EP2904989A1 (en) * | 2014-02-11 | 2015-08-12 | Kephalios S.A.S. | Adjustable annuloplasty device |
DK3389557T3 (en) | 2015-12-15 | 2022-08-01 | Neovasc Tiara Inc | Transseptalt leveringssystem |
EP3407835A4 (en) | 2016-01-29 | 2019-06-26 | Neovasc Tiara Inc. | Prosthetic valve for avoiding obstruction of outflow |
GB2548891B (en) | 2016-03-31 | 2018-07-04 | I Birdi Ltd | A prosthetic device for mitral valve repair |
CN107753153B (en) * | 2016-08-15 | 2022-05-31 | 沃卡尔有限公司 | Device and method for treating heart valve insufficiency |
JP2019535415A (en) | 2016-11-21 | 2019-12-12 | ニオバスク ティアラ インコーポレイテッド | Method and system for rapid retraction of a transcatheter heart valve delivery system |
ES2779850T3 (en) | 2017-04-28 | 2020-08-20 | Medtentia Int Ltd Oy | Annuloplasty implant |
US10856984B2 (en) | 2017-08-25 | 2020-12-08 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
CN108478310B (en) * | 2018-06-08 | 2024-05-03 | 倪一鸣 | Tricuspid valve forming ring with adjustable length and angle |
CN113271890B (en) | 2018-11-08 | 2024-08-30 | 内奥瓦斯克迪亚拉公司 | Ventricular deployment of transcatheter mitral valve prosthesis |
CN109620474B (en) * | 2018-11-24 | 2021-09-03 | 中国医学科学院阜外医院 | Extensible tricuspid valve forming ring |
AU2020233892A1 (en) | 2019-03-08 | 2021-11-04 | Neovasc Tiara Inc. | Retrievable prosthesis delivery system |
WO2020206012A1 (en) | 2019-04-01 | 2020-10-08 | Neovasc Tiara Inc. | Controllably deployable prosthetic valve |
CA3136334A1 (en) | 2019-04-10 | 2020-10-15 | Neovasc Tiara Inc. | Prosthetic valve with natural blood flow |
CA3140925A1 (en) | 2019-05-20 | 2020-11-26 | Neovasc Tiara Inc. | Introducer with hemostasis mechanism |
AU2020295566B2 (en) | 2019-06-20 | 2023-07-20 | Neovasc Tiara Inc. | Low profile prosthetic mitral valve |
TW202416917A (en) * | 2022-06-17 | 2024-05-01 | 美商4C醫療技術公司 | A prosthetic heart valve |
Citations (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3656185A (en) * | 1969-02-04 | 1972-04-18 | Rhone Poulenc Sa | Cardiac valvular support prosthesis |
US4055861A (en) * | 1975-04-11 | 1977-11-01 | Rhone-Poulenc Industries | Support for a natural human heart valve |
US4164046A (en) * | 1977-05-16 | 1979-08-14 | Cooley Denton | Valve prosthesis |
US4217665A (en) * | 1975-06-23 | 1980-08-19 | Societe D'utilisation Scientifique Et Industrielle Du Froid - Usifroid | Prosthesis for use in valvuloplasty |
US4602911A (en) * | 1982-08-19 | 1986-07-29 | General Resorts S.A. | Adjustable ringprosthesis |
US5041130A (en) * | 1989-07-31 | 1991-08-20 | Baxter International Inc. | Flexible annuloplasty ring and holder |
US5061277A (en) * | 1986-08-06 | 1991-10-29 | Baxter International Inc. | Flexible cardiac valvular support prosthesis |
US5064431A (en) * | 1991-01-16 | 1991-11-12 | St. Jude Medical Incorporated | Annuloplasty ring |
US5104407A (en) * | 1989-02-13 | 1992-04-14 | Baxter International Inc. | Selectively flexible annuloplasty ring |
US5201880A (en) * | 1992-01-27 | 1993-04-13 | Pioneering Technologies, Inc. | Mitral and tricuspid annuloplasty rings |
US5258021A (en) * | 1992-01-27 | 1993-11-02 | Duran Carlos G | Sigmoid valve annuloplasty ring |
US5306296A (en) * | 1992-08-21 | 1994-04-26 | Medtronic, Inc. | Annuloplasty and suture rings |
US5450860A (en) * | 1993-08-31 | 1995-09-19 | W. L. Gore & Associates, Inc. | Device for tissue repair and method for employing same |
US5496336A (en) * | 1989-07-31 | 1996-03-05 | Baxter International Inc. | Flexible suture guide and holder |
US5593435A (en) * | 1994-07-29 | 1997-01-14 | Baxter International Inc. | Distensible annuloplasty ring for surgical remodelling of an atrioventricular valve and nonsurgical method for post-implantation distension thereof to accommodate patient growth |
US5607471A (en) * | 1993-08-03 | 1997-03-04 | Jacques Seguin | Prosthetic ring for heart surgery |
US5674279A (en) * | 1992-01-27 | 1997-10-07 | Medtronic, Inc. | Annuloplasty and suture rings |
US5776189A (en) * | 1997-03-05 | 1998-07-07 | Khalid; Naqeeb | Cardiac valvular support prosthesis |
US5824069A (en) * | 1996-09-13 | 1998-10-20 | Medtronic, Inc. | Prosthetic heart valve with suturing member having non-uniform radial width |
US5824066A (en) * | 1995-12-01 | 1998-10-20 | Medtronic, Inc. | Annuloplasty prosthesis |
US5972030A (en) * | 1993-02-22 | 1999-10-26 | Heartport, Inc. | Less-invasive devices and methods for treatment of cardiac valves |
US6019739A (en) * | 1998-06-18 | 2000-02-01 | Baxter International Inc. | Minimally invasive valve annulus sizer |
US6024918A (en) * | 1998-03-13 | 2000-02-15 | Medtronic, Inc. | Method for attachment of biomolecules to surfaces of medical devices |
US6102945A (en) * | 1998-10-16 | 2000-08-15 | Sulzer Carbomedics, Inc. | Separable annuloplasty ring |
US6143024A (en) * | 1998-06-04 | 2000-11-07 | Sulzer Carbomedics Inc. | Annuloplasty ring having flexible anterior portion |
US6159240A (en) * | 1998-08-31 | 2000-12-12 | Medtronic, Inc. | Rigid annuloplasty device that becomes compliant after implantation |
US6183512B1 (en) * | 1999-04-16 | 2001-02-06 | Edwards Lifesciences Corporation | Flexible annuloplasty system |
US6187040B1 (en) * | 1999-05-03 | 2001-02-13 | John T. M. Wright | Mitral and tricuspid annuloplasty rings |
US6217610B1 (en) * | 1994-07-29 | 2001-04-17 | Edwards Lifesciences Corporation | Expandable annuloplasty ring |
US6231602B1 (en) * | 1999-04-16 | 2001-05-15 | Edwards Lifesciences Corporation | Aortic annuloplasty ring |
US6250308B1 (en) * | 1998-06-16 | 2001-06-26 | Cardiac Concepts, Inc. | Mitral valve annuloplasty ring and method of implanting |
US6258122B1 (en) * | 1995-11-01 | 2001-07-10 | St. Jude Medical, Inc. | Bioresorbable annuloplasty prosthesis |
US6406493B1 (en) * | 2000-06-02 | 2002-06-18 | Hosheng Tu | Expandable annuloplasty ring and methods of use |
US6419696B1 (en) * | 2000-07-06 | 2002-07-16 | Paul A. Spence | Annuloplasty devices and related heart valve repair methods |
US20020129820A1 (en) * | 2001-03-15 | 2002-09-19 | Medtronic, Inc | Annuloplasty band and method |
US20020133180A1 (en) * | 2001-03-15 | 2002-09-19 | Ryan Timothy R. | Annuloplasty band and method |
US20020169504A1 (en) * | 2001-05-14 | 2002-11-14 | Alferness Clifton A. | Mitral valve therapy device, system and method |
US20020173844A1 (en) * | 2001-05-17 | 2002-11-21 | Ottavio Alfieri | Annular prosthesis for mitral valve |
US20030033009A1 (en) * | 2000-05-22 | 2003-02-13 | Shlomo Gabbay | Cardiac prosthesis for helping improve operation of a heat valve |
US20030040793A1 (en) * | 2001-08-24 | 2003-02-27 | Salvador Marquez | Self-molding annuloplasty ring and method of use |
US20030083742A1 (en) * | 2000-02-02 | 2003-05-01 | Paul A. Spence | Heart valve repair apparatus and methods |
US20030093148A1 (en) * | 2001-11-13 | 2003-05-15 | Bolling Steven F. | Mitral valve annuloplasty ring for molding left ventricle geometry |
US6602288B1 (en) * | 2000-10-05 | 2003-08-05 | Edwards Lifesciences Corporation | Minimally-invasive annuloplasty repair segment delivery template, system and method of use |
US6602289B1 (en) * | 1999-06-08 | 2003-08-05 | S&A Rings, Llc | Annuloplasty rings of particular use in surgery for the mitral valve |
US6619291B2 (en) * | 2001-04-24 | 2003-09-16 | Edwin J. Hlavka | Method and apparatus for catheter-based annuloplasty |
US20030208264A1 (en) * | 2001-08-28 | 2003-11-06 | Mccarthy Patrick M. | Three-dimensional annuloplasty ring and template |
US20040006384A1 (en) * | 2002-07-08 | 2004-01-08 | Mccarthy Patrick | Mitral valve annuluplasty ring having a posterior bow |
US6709456B2 (en) * | 2000-01-31 | 2004-03-23 | Ev3 Santa Rosa, Inc. | Percutaneous mitral annuloplasty with hemodynamic monitoring |
US6719786B2 (en) * | 2002-03-18 | 2004-04-13 | Medtronic, Inc. | Flexible annuloplasty prosthesis and holder |
US6749639B2 (en) * | 2001-08-27 | 2004-06-15 | Mayo Foundation For Medical Education And Research | Coated prosthetic implant |
US20040249453A1 (en) * | 2002-08-29 | 2004-12-09 | Cartledge Richard G. | Methods for controlling the internal circumference of an anatomic orifice or lumen |
US20040249452A1 (en) * | 2001-11-01 | 2004-12-09 | Adams John M. | Focused compression mitral valve device and method |
US20050043791A1 (en) * | 2001-08-28 | 2005-02-24 | Mccarthy Patrick M. | Three-dimensional annuloplasty ring and template |
US20050131533A1 (en) * | 2001-05-17 | 2005-06-16 | Ottavio Alfieri | Annuloplasty rings for repair of abnormal mitral valves |
US6918917B1 (en) * | 2000-10-10 | 2005-07-19 | Medtronic, Inc. | Minimally invasive annuloplasty procedure and apparatus |
US20050192666A1 (en) * | 2002-07-08 | 2005-09-01 | Mccarthy Patrick | Mitral valve annuloplasty ring having a posterior bow |
US20050197696A1 (en) * | 2004-02-23 | 2005-09-08 | Gomez Duran Carlos M. | Papilloplasty band and sizing device |
US6942694B2 (en) * | 2000-01-14 | 2005-09-13 | Viacor, Inc. | Tissue annuloplasty band and apparatus and method for fashioning, sizing and implanting the same |
US20050246014A1 (en) * | 2004-04-29 | 2005-11-03 | Mccarthy Patrick M | Annuloplasty ring for mitral valve prolapse |
US20050256568A1 (en) * | 2004-05-14 | 2005-11-17 | St. Jude Medical, Inc. | C-shaped heart valve prostheses |
US20050256567A1 (en) * | 2004-05-14 | 2005-11-17 | St. Jude Medical, Inc. | Heart valve annuloplasty prosthesis sewing cuffs and methods of making same |
US20050256569A1 (en) * | 2004-05-14 | 2005-11-17 | St. Jude Medical, Inc. | Flexible, non-planar annuloplasty rings |
US6966924B2 (en) * | 2002-08-16 | 2005-11-22 | St. Jude Medical, Inc. | Annuloplasty ring holder |
US20050267572A1 (en) * | 2004-05-14 | 2005-12-01 | St. Jude Medical, Inc. | Systems and methods for holding annuloplasty rings |
US20050278022A1 (en) * | 2004-06-14 | 2005-12-15 | St. Jude Medical, Inc. | Annuloplasty prostheses with improved anchoring structures, and related methods |
US20050288777A1 (en) * | 2004-06-29 | 2005-12-29 | Rhee Richard S | Thermal conductor for adjustable cardiac valve implant |
US6986775B2 (en) * | 2002-06-13 | 2006-01-17 | Guided Delivery Systems, Inc. | Devices and methods for heart valve repair |
US20060015179A1 (en) * | 2004-07-19 | 2006-01-19 | Neil Bulman-Fleming | Aortic annuloplasty ring |
US20060015178A1 (en) * | 2004-07-15 | 2006-01-19 | Shahram Moaddeb | Implants and methods for reshaping heart valves |
US20060020336A1 (en) * | 2001-10-23 | 2006-01-26 | Liddicoat John R | Automated annular plication for mitral valve repair |
US20060025858A1 (en) * | 2004-07-27 | 2006-02-02 | Alameddine Abdallah K | Mitral valve ring for treatment of mitral valve regurgitation |
US7037334B1 (en) * | 2001-04-24 | 2006-05-02 | Mitralign, Inc. | Method and apparatus for catheter-based annuloplasty using local plications |
US20060206203A1 (en) * | 2005-03-10 | 2006-09-14 | Jun Yang | Valvular support prosthesis |
US7118595B2 (en) * | 2002-03-18 | 2006-10-10 | Medtronic, Inc. | Flexible annuloplasty prosthesis and holder |
US7125421B2 (en) * | 2001-08-31 | 2006-10-24 | Mitral Interventions, Inc. | Method and apparatus for valve repair |
US7166127B2 (en) * | 2003-12-23 | 2007-01-23 | Mitralign, Inc. | Tissue fastening systems and methods utilizing magnetic guidance |
US20080086203A1 (en) * | 2006-10-06 | 2008-04-10 | Roberts Harold G | Mitral and tricuspid annuloplasty rings |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4489446A (en) | 1982-07-14 | 1984-12-25 | Reed Charles C | Heart valve prosthesis |
IT1218951B (en) | 1988-01-12 | 1990-04-24 | Mario Morea | PROSTHETIC DEVICE FOR SURGICAL CORRECTION OF TRICUSPIDAL INSUFFICENCE |
US4917698A (en) * | 1988-12-22 | 1990-04-17 | Baxter International Inc. | Multi-segmented annuloplasty ring prosthesis |
US7883539B2 (en) | 1997-01-02 | 2011-02-08 | Edwards Lifesciences Llc | Heart wall tension reduction apparatus and method |
EP0860151A1 (en) | 1997-02-25 | 1998-08-26 | Naqeeb Khalid | Cardiac valvular support prosthesis |
US6001127A (en) | 1998-03-31 | 1999-12-14 | St. Jude Medical, Inc. | Annuloplasty ring holder |
DE19910233A1 (en) | 1999-03-09 | 2000-09-21 | Jostra Medizintechnik Ag | Anuloplasty prosthesis |
FR2799364B1 (en) | 1999-10-12 | 2001-11-23 | Jacques Seguin | MINIMALLY INVASIVE CANCELING DEVICE |
WO2001047438A1 (en) | 1999-12-23 | 2001-07-05 | Edwards Lifesciences Corporation | Enhanced visualization of medical implants |
US6368348B1 (en) | 2000-05-15 | 2002-04-09 | Shlomo Gabbay | Annuloplasty prosthesis for supporting an annulus of a heart valve |
US6749630B2 (en) * | 2001-08-28 | 2004-06-15 | Edwards Lifesciences Corporation | Tricuspid ring and template |
US7087064B1 (en) | 2002-10-15 | 2006-08-08 | Advanced Cardiovascular Systems, Inc. | Apparatuses and methods for heart valve repair |
JP4594316B2 (en) | 2003-10-03 | 2010-12-08 | エドワーズ ライフサイエンシーズ コーポレイション | Annuloplasty ring for repair of abnormal mitral valve |
US7951196B2 (en) * | 2004-04-29 | 2011-05-31 | Edwards Lifesciences Corporation | Annuloplasty ring for mitral valve prolapse |
EP1951154B1 (en) | 2005-10-26 | 2018-01-24 | St. Jude Medical, Inc. | Saddle-shaped mitral valve annuloplasty prostheses |
CA2676541C (en) * | 2007-01-26 | 2015-08-11 | Medtronic, Inc. | Annuloplasty device for tricuspid valve repair |
US8529620B2 (en) * | 2007-05-01 | 2013-09-10 | Ottavio Alfieri | Inwardly-bowed tricuspid annuloplasty ring |
US20090287303A1 (en) | 2008-05-13 | 2009-11-19 | Edwards Lifesciences Corporation | Physiologically harmonized tricuspid annuloplasty ring |
-
2008
- 2008-05-13 US US12/120,184 patent/US20090287303A1/en not_active Abandoned
- 2008-05-15 JP JP2011509457A patent/JP5390598B2/en active Active
- 2008-05-15 EP EP08755581.9A patent/EP2306933B1/en active Active
- 2008-05-15 WO PCT/US2008/063758 patent/WO2009139776A1/en active Application Filing
- 2008-05-15 CA CA2721143A patent/CA2721143C/en active Active
- 2008-05-15 CN CN200880129174.0A patent/CN102088930B/en active Active
-
2012
- 2012-08-30 US US13/600,040 patent/US9937041B2/en active Active
-
2018
- 2018-03-30 US US15/941,499 patent/US20180221150A1/en not_active Abandoned
-
2021
- 2021-08-27 US US17/459,211 patent/US11903830B2/en active Active
-
2024
- 2024-01-26 US US18/424,397 patent/US20240156597A1/en active Pending
Patent Citations (101)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3656185A (en) * | 1969-02-04 | 1972-04-18 | Rhone Poulenc Sa | Cardiac valvular support prosthesis |
US4055861A (en) * | 1975-04-11 | 1977-11-01 | Rhone-Poulenc Industries | Support for a natural human heart valve |
US4217665A (en) * | 1975-06-23 | 1980-08-19 | Societe D'utilisation Scientifique Et Industrielle Du Froid - Usifroid | Prosthesis for use in valvuloplasty |
US4164046A (en) * | 1977-05-16 | 1979-08-14 | Cooley Denton | Valve prosthesis |
US4602911A (en) * | 1982-08-19 | 1986-07-29 | General Resorts S.A. | Adjustable ringprosthesis |
US5061277A (en) * | 1986-08-06 | 1991-10-29 | Baxter International Inc. | Flexible cardiac valvular support prosthesis |
US5061277B1 (en) * | 1986-08-06 | 2000-02-29 | Baxter Travenol Lab | Flexible cardiac valvular support prosthesis |
US5104407A (en) * | 1989-02-13 | 1992-04-14 | Baxter International Inc. | Selectively flexible annuloplasty ring |
US5104407B1 (en) * | 1989-02-13 | 1999-09-21 | Baxter Int | Selectively flexible annuloplasty ring |
US5496336A (en) * | 1989-07-31 | 1996-03-05 | Baxter International Inc. | Flexible suture guide and holder |
US5041130A (en) * | 1989-07-31 | 1991-08-20 | Baxter International Inc. | Flexible annuloplasty ring and holder |
US6802860B2 (en) * | 1989-07-31 | 2004-10-12 | Edwards Lifesciences Corporation | Annuloplasty ring delivery system |
US5064431A (en) * | 1991-01-16 | 1991-11-12 | St. Jude Medical Incorporated | Annuloplasty ring |
US5674279A (en) * | 1992-01-27 | 1997-10-07 | Medtronic, Inc. | Annuloplasty and suture rings |
US5201880A (en) * | 1992-01-27 | 1993-04-13 | Pioneering Technologies, Inc. | Mitral and tricuspid annuloplasty rings |
US5258021A (en) * | 1992-01-27 | 1993-11-02 | Duran Carlos G | Sigmoid valve annuloplasty ring |
US5306296A (en) * | 1992-08-21 | 1994-04-26 | Medtronic, Inc. | Annuloplasty and suture rings |
US5972030A (en) * | 1993-02-22 | 1999-10-26 | Heartport, Inc. | Less-invasive devices and methods for treatment of cardiac valves |
US5607471A (en) * | 1993-08-03 | 1997-03-04 | Jacques Seguin | Prosthetic ring for heart surgery |
US5450860A (en) * | 1993-08-31 | 1995-09-19 | W. L. Gore & Associates, Inc. | Device for tissue repair and method for employing same |
US5888240A (en) * | 1994-07-29 | 1999-03-30 | Baxter International Inc. | Distensible annuloplasty ring for surgical remodelling of an atrioventricular valve and nonsurgical method for post-implantation distension thereof to accomodate patient growth |
US5593435A (en) * | 1994-07-29 | 1997-01-14 | Baxter International Inc. | Distensible annuloplasty ring for surgical remodelling of an atrioventricular valve and nonsurgical method for post-implantation distension thereof to accommodate patient growth |
US6217610B1 (en) * | 1994-07-29 | 2001-04-17 | Edwards Lifesciences Corporation | Expandable annuloplasty ring |
US6391054B2 (en) * | 1994-07-29 | 2002-05-21 | Edwards Lifesciences Corporation | Expandable annuloplasty ring |
US6258122B1 (en) * | 1995-11-01 | 2001-07-10 | St. Jude Medical, Inc. | Bioresorbable annuloplasty prosthesis |
US5824066A (en) * | 1995-12-01 | 1998-10-20 | Medtronic, Inc. | Annuloplasty prosthesis |
US5824069A (en) * | 1996-09-13 | 1998-10-20 | Medtronic, Inc. | Prosthetic heart valve with suturing member having non-uniform radial width |
US5776189A (en) * | 1997-03-05 | 1998-07-07 | Khalid; Naqeeb | Cardiac valvular support prosthesis |
US6024918A (en) * | 1998-03-13 | 2000-02-15 | Medtronic, Inc. | Method for attachment of biomolecules to surfaces of medical devices |
US6143024A (en) * | 1998-06-04 | 2000-11-07 | Sulzer Carbomedics Inc. | Annuloplasty ring having flexible anterior portion |
US6250308B1 (en) * | 1998-06-16 | 2001-06-26 | Cardiac Concepts, Inc. | Mitral valve annuloplasty ring and method of implanting |
US20010034551A1 (en) * | 1998-06-16 | 2001-10-25 | Cardiac Concepts, Inc. | Mitral valve annuloplasty ring and method of implanting |
US6019739A (en) * | 1998-06-18 | 2000-02-01 | Baxter International Inc. | Minimally invasive valve annulus sizer |
US6159240A (en) * | 1998-08-31 | 2000-12-12 | Medtronic, Inc. | Rigid annuloplasty device that becomes compliant after implantation |
US6102945A (en) * | 1998-10-16 | 2000-08-15 | Sulzer Carbomedics, Inc. | Separable annuloplasty ring |
US6231602B1 (en) * | 1999-04-16 | 2001-05-15 | Edwards Lifesciences Corporation | Aortic annuloplasty ring |
US6183512B1 (en) * | 1999-04-16 | 2001-02-06 | Edwards Lifesciences Corporation | Flexible annuloplasty system |
US6187040B1 (en) * | 1999-05-03 | 2001-02-13 | John T. M. Wright | Mitral and tricuspid annuloplasty rings |
US6602289B1 (en) * | 1999-06-08 | 2003-08-05 | S&A Rings, Llc | Annuloplasty rings of particular use in surgery for the mitral valve |
US6942694B2 (en) * | 2000-01-14 | 2005-09-13 | Viacor, Inc. | Tissue annuloplasty band and apparatus and method for fashioning, sizing and implanting the same |
US6709456B2 (en) * | 2000-01-31 | 2004-03-23 | Ev3 Santa Rosa, Inc. | Percutaneous mitral annuloplasty with hemodynamic monitoring |
US6797002B2 (en) * | 2000-02-02 | 2004-09-28 | Paul A. Spence | Heart valve repair apparatus and methods |
US20030083742A1 (en) * | 2000-02-02 | 2003-05-01 | Paul A. Spence | Heart valve repair apparatus and methods |
US7166126B2 (en) * | 2000-02-02 | 2007-01-23 | Paul A. Spence | Heart valve repair apparatus and methods |
US20030033009A1 (en) * | 2000-05-22 | 2003-02-13 | Shlomo Gabbay | Cardiac prosthesis for helping improve operation of a heat valve |
US6406493B1 (en) * | 2000-06-02 | 2002-06-18 | Hosheng Tu | Expandable annuloplasty ring and methods of use |
US6419696B1 (en) * | 2000-07-06 | 2002-07-16 | Paul A. Spence | Annuloplasty devices and related heart valve repair methods |
US6602288B1 (en) * | 2000-10-05 | 2003-08-05 | Edwards Lifesciences Corporation | Minimally-invasive annuloplasty repair segment delivery template, system and method of use |
US6921407B2 (en) * | 2000-10-10 | 2005-07-26 | Medtronic, Inc. | Minimally invasive annuloplasty procedure and apparatus |
US6918917B1 (en) * | 2000-10-10 | 2005-07-19 | Medtronic, Inc. | Minimally invasive annuloplasty procedure and apparatus |
US20020129820A1 (en) * | 2001-03-15 | 2002-09-19 | Medtronic, Inc | Annuloplasty band and method |
US6955689B2 (en) * | 2001-03-15 | 2005-10-18 | Medtronic, Inc. | Annuloplasty band and method |
US20020133180A1 (en) * | 2001-03-15 | 2002-09-19 | Ryan Timothy R. | Annuloplasty band and method |
US20060025856A1 (en) * | 2001-03-15 | 2006-02-02 | Medtronic, Inc. | Annuloplasty band and method |
US6718985B2 (en) * | 2001-04-24 | 2004-04-13 | Edwin J. Hlavka | Method and apparatus for catheter-based annuloplasty using local plications |
US7037334B1 (en) * | 2001-04-24 | 2006-05-02 | Mitralign, Inc. | Method and apparatus for catheter-based annuloplasty using local plications |
US6619291B2 (en) * | 2001-04-24 | 2003-09-16 | Edwin J. Hlavka | Method and apparatus for catheter-based annuloplasty |
US6800090B2 (en) * | 2001-05-14 | 2004-10-05 | Cardiac Dimensions, Inc. | Mitral valve therapy device, system and method |
US20020169504A1 (en) * | 2001-05-14 | 2002-11-14 | Alferness Clifton A. | Mitral valve therapy device, system and method |
US6726717B2 (en) * | 2001-05-17 | 2004-04-27 | Edwards Lifesciences Corporation | Annular prosthesis for mitral valve |
US20020173844A1 (en) * | 2001-05-17 | 2002-11-21 | Ottavio Alfieri | Annular prosthesis for mitral valve |
US20050004666A1 (en) * | 2001-05-17 | 2005-01-06 | Ottavio Alfieri | Annular prosthesis for mitral valve |
US20050131533A1 (en) * | 2001-05-17 | 2005-06-16 | Ottavio Alfieri | Annuloplasty rings for repair of abnormal mitral valves |
US20030040793A1 (en) * | 2001-08-24 | 2003-02-27 | Salvador Marquez | Self-molding annuloplasty ring and method of use |
US6749639B2 (en) * | 2001-08-27 | 2004-06-15 | Mayo Foundation For Medical Education And Research | Coated prosthetic implant |
US20030208264A1 (en) * | 2001-08-28 | 2003-11-06 | Mccarthy Patrick M. | Three-dimensional annuloplasty ring and template |
US6908482B2 (en) * | 2001-08-28 | 2005-06-21 | Edwards Lifesciences Corporation | Three-dimensional annuloplasty ring and template |
US20050182487A1 (en) * | 2001-08-28 | 2005-08-18 | Mccarthy Patrick M. | Three-dimensional annuloplasty ring and template |
US20050043791A1 (en) * | 2001-08-28 | 2005-02-24 | Mccarthy Patrick M. | Three-dimensional annuloplasty ring and template |
US7125421B2 (en) * | 2001-08-31 | 2006-10-24 | Mitral Interventions, Inc. | Method and apparatus for valve repair |
US20060020336A1 (en) * | 2001-10-23 | 2006-01-26 | Liddicoat John R | Automated annular plication for mitral valve repair |
US20040249452A1 (en) * | 2001-11-01 | 2004-12-09 | Adams John M. | Focused compression mitral valve device and method |
US7329280B2 (en) * | 2001-11-13 | 2008-02-12 | Edwards Lifesciences Corp. | Methods of implanting a mitral valve annuloplasty ring to correct mitral regurgitation |
US20030093148A1 (en) * | 2001-11-13 | 2003-05-15 | Bolling Steven F. | Mitral valve annuloplasty ring for molding left ventricle geometry |
US6805710B2 (en) * | 2001-11-13 | 2004-10-19 | Edwards Lifesciences Corporation | Mitral valve annuloplasty ring for molding left ventricle geometry |
US6719786B2 (en) * | 2002-03-18 | 2004-04-13 | Medtronic, Inc. | Flexible annuloplasty prosthesis and holder |
US7118595B2 (en) * | 2002-03-18 | 2006-10-10 | Medtronic, Inc. | Flexible annuloplasty prosthesis and holder |
US7066954B2 (en) * | 2002-03-18 | 2006-06-27 | Medtronic, Inc. | Annuloplasty system |
US6986775B2 (en) * | 2002-06-13 | 2006-01-17 | Guided Delivery Systems, Inc. | Devices and methods for heart valve repair |
US6858039B2 (en) * | 2002-07-08 | 2005-02-22 | Edwards Lifesciences Corporation | Mitral valve annuloplasty ring having a posterior bow |
US20050192666A1 (en) * | 2002-07-08 | 2005-09-01 | Mccarthy Patrick | Mitral valve annuloplasty ring having a posterior bow |
US20040006384A1 (en) * | 2002-07-08 | 2004-01-08 | Mccarthy Patrick | Mitral valve annuluplasty ring having a posterior bow |
US6966924B2 (en) * | 2002-08-16 | 2005-11-22 | St. Jude Medical, Inc. | Annuloplasty ring holder |
US20040249453A1 (en) * | 2002-08-29 | 2004-12-09 | Cartledge Richard G. | Methods for controlling the internal circumference of an anatomic orifice or lumen |
US7166127B2 (en) * | 2003-12-23 | 2007-01-23 | Mitralign, Inc. | Tissue fastening systems and methods utilizing magnetic guidance |
US20050197696A1 (en) * | 2004-02-23 | 2005-09-08 | Gomez Duran Carlos M. | Papilloplasty band and sizing device |
US20050246014A1 (en) * | 2004-04-29 | 2005-11-03 | Mccarthy Patrick M | Annuloplasty ring for mitral valve prolapse |
US7294148B2 (en) * | 2004-04-29 | 2007-11-13 | Edwards Lifesciences Corporation | Annuloplasty ring for mitral valve prolapse |
US20050256569A1 (en) * | 2004-05-14 | 2005-11-17 | St. Jude Medical, Inc. | Flexible, non-planar annuloplasty rings |
US20050256568A1 (en) * | 2004-05-14 | 2005-11-17 | St. Jude Medical, Inc. | C-shaped heart valve prostheses |
US20050256567A1 (en) * | 2004-05-14 | 2005-11-17 | St. Jude Medical, Inc. | Heart valve annuloplasty prosthesis sewing cuffs and methods of making same |
US20050267572A1 (en) * | 2004-05-14 | 2005-12-01 | St. Jude Medical, Inc. | Systems and methods for holding annuloplasty rings |
US20050278022A1 (en) * | 2004-06-14 | 2005-12-15 | St. Jude Medical, Inc. | Annuloplasty prostheses with improved anchoring structures, and related methods |
US20050288778A1 (en) * | 2004-06-29 | 2005-12-29 | Emanuel Shaoulian | Selectively adjustable cardiac valve implants |
US20050288776A1 (en) * | 2004-06-29 | 2005-12-29 | Emanuel Shaoulian | Adjustable cardiac valve implant with coupling mechanism |
US20050288777A1 (en) * | 2004-06-29 | 2005-12-29 | Rhee Richard S | Thermal conductor for adjustable cardiac valve implant |
US20060015178A1 (en) * | 2004-07-15 | 2006-01-19 | Shahram Moaddeb | Implants and methods for reshaping heart valves |
US20060015179A1 (en) * | 2004-07-19 | 2006-01-19 | Neil Bulman-Fleming | Aortic annuloplasty ring |
US20060025858A1 (en) * | 2004-07-27 | 2006-02-02 | Alameddine Abdallah K | Mitral valve ring for treatment of mitral valve regurgitation |
US20060206203A1 (en) * | 2005-03-10 | 2006-09-14 | Jun Yang | Valvular support prosthesis |
US20080086203A1 (en) * | 2006-10-06 | 2008-04-10 | Roberts Harold G | Mitral and tricuspid annuloplasty rings |
Cited By (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10166101B2 (en) | 2001-05-17 | 2019-01-01 | Edwards Lifesciences Corporation | Methods for repairing mitral valves |
US9414922B2 (en) | 2001-08-28 | 2016-08-16 | Edwards Lifesciences Corporation | Three-dimensional annuloplasty ring |
US20080208331A1 (en) * | 2001-08-28 | 2008-08-28 | Edwards Lifesciences Corporation | Annuloplasty ring with offset free ends |
US9149359B2 (en) | 2001-08-28 | 2015-10-06 | Edwards Lifesciences Corporation | Three-dimensional annuloplasty ring |
US8114155B2 (en) * | 2001-08-28 | 2012-02-14 | Edwards Lifesciences Corporation | Annuloplasty ring with offset free ends |
US10188518B2 (en) | 2001-08-28 | 2019-01-29 | Edwards Lifesciences Corporation | Annuloplasty ring with variable cross-section |
US7879087B2 (en) * | 2006-10-06 | 2011-02-01 | Edwards Lifesciences Corporation | Mitral and tricuspid annuloplasty rings |
US20110093065A1 (en) * | 2006-10-06 | 2011-04-21 | Edwards Lifesciences Corporation | Mitral and Tricuspid Annuloplasty Rings |
US8382828B2 (en) * | 2006-10-06 | 2013-02-26 | Edwards Lifesciences Corporation | Mitral annuloplasty rings |
US7959673B2 (en) * | 2007-02-09 | 2011-06-14 | Edwards Lifesciences Corporation | Degenerative valvular disease specific annuloplasty rings |
US8764821B2 (en) | 2007-02-09 | 2014-07-01 | Edwards Lifesciences Corporation | Degenerative vavlular disease specific annuloplasty ring sets |
US8529620B2 (en) * | 2007-05-01 | 2013-09-10 | Ottavio Alfieri | Inwardly-bowed tricuspid annuloplasty ring |
US20080275551A1 (en) * | 2007-05-01 | 2008-11-06 | Edwards Lifesciences Corporation | Inwardly-bowed tricuspid annuloplasty ring |
US9101472B2 (en) | 2007-09-07 | 2015-08-11 | Edwards Lifesciences Corporation | Active holder for annuloplasty ring delivery |
US11576784B2 (en) | 2007-09-07 | 2023-02-14 | Edwards Lifesciences Corporation | Active holder for annuloplasty ring delivery |
US10842629B2 (en) | 2007-09-07 | 2020-11-24 | Edwards Lifesciences Corporation | Active holder for annuloplasty ring delivery |
US7993395B2 (en) | 2008-01-25 | 2011-08-09 | Medtronic, Inc. | Set of annuloplasty devices with varying anterior-posterior ratios and related methods |
US20120022643A1 (en) * | 2008-01-25 | 2012-01-26 | Hugo Vanermen | Set of Annuloplasty Devices with Varying Anterior-Posterior Ratios and Related Methods |
US8795353B2 (en) | 2008-01-25 | 2014-08-05 | Medtronic, Inc. | Holder devices for annuloplasty devices having a plurality of anterior-posterior ratios |
US8961598B2 (en) * | 2008-01-25 | 2015-02-24 | Medtronic, Inc. | Set of annuloplasty devices with varying anterior-posterior ratios and related methods |
US20090192606A1 (en) * | 2008-01-25 | 2009-07-30 | Medtronic, Inc. | Holder Devices for Annuloplasty Devices Having a Plurality of Anterior-Posterior Ratios |
US20090192605A1 (en) * | 2008-01-25 | 2009-07-30 | Medtronic, Inc. | Sizer Device Having a Plurality of Anterior-Posterior Ratios |
US11903830B2 (en) | 2008-05-13 | 2024-02-20 | Edwards Lifesciences Corporation | Physiologically harmonized repair of tricuspid valve |
US9937041B2 (en) | 2008-05-13 | 2018-04-10 | Edwards Lifesciences Corporation | Physiologically harmonized tricuspid annuloplasty ring |
CN102985031A (en) * | 2010-02-03 | 2013-03-20 | 美敦力Gbi有限公司 | Semi-flexible annuloplasty ring |
US20210161665A1 (en) * | 2010-02-03 | 2021-06-03 | Medtronic ATS Medical, Inc. | Semi-flexible annuloplasty ring |
WO2011097251A1 (en) * | 2010-02-03 | 2011-08-11 | Genesee Biomedical, Inc. | Semi-flexible annuloplasty ring |
US8556966B2 (en) * | 2010-03-23 | 2013-10-15 | Boston Scientific Scimed, Inc. | Annuloplasty device |
US20110238169A1 (en) * | 2010-03-23 | 2011-09-29 | Boston Scientific Scimed, Inc. | Annuloplasty device |
US10940003B2 (en) | 2010-08-24 | 2021-03-09 | Edwards Lifesciences Corporation | Methods of delivering a flexible annuloplasty ring |
US10182912B2 (en) | 2010-08-24 | 2019-01-22 | Edwards Lifesciences Corporation | Methods of delivering a flexible annuloplasty ring |
US9326858B2 (en) | 2010-08-24 | 2016-05-03 | Edwards Lifesciences Corporation | Flexible annuloplasty ring |
US8915960B2 (en) | 2010-08-31 | 2014-12-23 | Edwards Lifesciences Corporation | Physiologic tricuspid annuloplasty ring |
US9474607B2 (en) * | 2010-11-30 | 2016-10-25 | Edwards Lifesciences Corporation | Methods of implanting an annuloplasty ring for reduced dehiscence |
US20150127099A1 (en) * | 2010-11-30 | 2015-05-07 | Edwards Lifesciences Corporation | Methods of implanting an annuloplasty ring for reduced dehiscence |
US8932350B2 (en) * | 2010-11-30 | 2015-01-13 | Edwards Lifesciences Corporation | Reduced dehiscence annuloplasty ring |
US20120136435A1 (en) * | 2010-11-30 | 2012-05-31 | Edwards Lifesciences Corporation | Reduced Dehiscence Annuloplasty Ring |
WO2012074993A3 (en) * | 2010-11-30 | 2012-08-16 | Edwards Lifesciences Corporation | Reduced dehiscence annuloplasty ring |
US10543089B2 (en) | 2010-11-30 | 2020-01-28 | Edwards Lifesciences Corporation | Annuloplasty ring with reduced dehiscence |
US11872132B2 (en) * | 2010-11-30 | 2024-01-16 | Edwards Lifesciences Corporation | Methods of implanting an annuloplasty ring for reduced dehiscence |
CN103249376A (en) * | 2010-11-30 | 2013-08-14 | 爱德华兹生命科学公司 | Reduced dehiscence annuloplasty ring |
WO2012152959A1 (en) * | 2011-05-06 | 2012-11-15 | Sarraj Asil Anas | Kit for anuloplasty of the tricuspid valve |
ES2392416A1 (en) * | 2011-05-06 | 2012-12-10 | Anas SARRAJ ASIL | Kit for anuloplasty of the tricuspid valve |
US9687346B2 (en) | 2013-03-14 | 2017-06-27 | Edwards Lifesciences Corporation | Multi-stranded heat set annuloplasty rings |
US10265171B2 (en) | 2013-03-14 | 2019-04-23 | Edwards Lifesciences Corporation | Multi-stranded heat set annuloplasty rings |
US11045319B2 (en) | 2013-03-14 | 2021-06-29 | Edwards Lifesciences Corporation | Methods of forming heat set annuloplasty rings |
US11471280B2 (en) * | 2015-06-09 | 2022-10-18 | Edwards Lifesciences, Llc | Asymmetric mitral annuloplasty band |
WO2016201084A1 (en) * | 2015-06-09 | 2016-12-15 | Edwards Lifesciences, Llc | Asymmetric mitral annuloplasty band |
US11324593B2 (en) | 2015-06-09 | 2022-05-10 | Edwards Lifesciences, Llc | Asymmetric mitral annuloplasty band |
US11938027B2 (en) * | 2015-06-09 | 2024-03-26 | Edwards Lifesciences, Llc | Asymmetric mitral annuloplasty band |
CN111529132A (en) * | 2015-06-09 | 2020-08-14 | 爱德华兹生命科学有限责任公司 | Asymmetrical mitral annuloplasty band |
US20160361170A1 (en) * | 2015-06-09 | 2016-12-15 | Edwards Lifesciences, Llc | Asymmetric mitral annuloplasty band |
US10314707B2 (en) * | 2015-06-09 | 2019-06-11 | Edwards Lifesciences, Llc | Asymmetric mitral annuloplasty band |
CN112437650A (en) * | 2018-05-16 | 2021-03-02 | 李米德基金会 | Semi-rigid annuloplasty ring and method of making same |
US11918467B2 (en) | 2018-05-16 | 2024-03-05 | Fondazione Ri. Med | Semi-rigid annuloplasty ring and method of manufacturing |
US11554015B2 (en) | 2018-07-30 | 2023-01-17 | Edwards Lifesciences Corporation | Minimally-invasive low strain annuloplasty ring |
US11653815B2 (en) * | 2018-08-30 | 2023-05-23 | Olympus Corporation | Recording device, image observation device, observation system, control method of observation system, and computer-readable recording medium |
US20210192836A1 (en) * | 2018-08-30 | 2021-06-24 | Olympus Corporation | Recording device, image observation device, observation system, control method of observation system, and computer-readable recording medium |
US11491008B2 (en) * | 2019-07-11 | 2022-11-08 | Medtentia International Ltd Oy | Annuloplasty device |
US20220202570A1 (en) * | 2019-07-11 | 2022-06-30 | Medtentia International Ltd Oy | Annuloplasty Device |
Also Published As
Publication number | Publication date |
---|---|
US11903830B2 (en) | 2024-02-20 |
CA2721143C (en) | 2013-06-25 |
US20120330412A1 (en) | 2012-12-27 |
JP2011520505A (en) | 2011-07-21 |
EP2306933A1 (en) | 2011-04-13 |
US20180221150A1 (en) | 2018-08-09 |
CN102088930B (en) | 2014-10-15 |
JP5390598B2 (en) | 2014-01-15 |
US9937041B2 (en) | 2018-04-10 |
US20240156597A1 (en) | 2024-05-16 |
CA2721143A1 (en) | 2009-11-19 |
CN102088930A (en) | 2011-06-08 |
EP2306933B1 (en) | 2014-06-04 |
US20210401577A1 (en) | 2021-12-30 |
WO2009139776A1 (en) | 2009-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11903830B2 (en) | Physiologically harmonized repair of tricuspid valve | |
US11872132B2 (en) | Methods of implanting an annuloplasty ring for reduced dehiscence | |
JP7522080B2 (en) | Asymmetric mitral annuloplasty band | |
US8449608B2 (en) | Tricuspid ring | |
EP2142144B1 (en) | Inwardly-bowed tricuspid annuloplasty ring | |
US20110160849A1 (en) | Bimodal tricuspid annuloplasty ring | |
EP1986574A1 (en) | Annuloplasty ring for mitral valve prolapse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: EDWARDS LIFESCIENCES CORPORATION, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CARPENTIER, ALAIN;REEL/FRAME:021414/0665 Effective date: 20080711 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |